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Abstract 
 
Mycobacterium tuberculosis, the causative agent of tuberculosis (TB) has 
infected one third of the world’s population and continues to claim more lives 
annually than any other infectious disease agent. A significant proportion of 
individuals carry latent TB infection (LBTI) which is characterized by the absence 
of clinical symptoms and it has been postulated that the tubercle bacilli are in a 
dormant-like state during this type of infection. Resuscitation promoting factors 
(Rpfs) are cell wall hydrolases which cleave glycosidic bonds within the 
peptidoglycan (PG), a mechanism thought to result in reactivation of bacteria 
from the state of dormancy. M. tuberculosis encodes five rpf-like homologues 
which are collectively dispensable for growth but are required for reactivation 
from dormancy in vitro, and for virulence in the mouse model of infection. LTBI 
thus poses a huge threat to the global burden of active disease. The purpose of 
this study was to further investigate the biological roles of Rpfs by assessing the 
effects of rpf gene deletion in M. smegmatis, a model organism used for TB 
research. M. smegmatis encodes four rpf-like genes designated rpfA, rpfB, rpfC 
and rpfE, and deletion mutants that lack one or more of these genes were 
constructed by allelic exchange mutagenesis. M. smegmatis mutant strains that 
lack either rpfA or rpfB display no significant differences in growth both on solid 
and in liquid medium when compared to wild type. However, loss of rpfA resulted 
in bacterial clumping during stationary-phase growth in broth culture and 
changes in cell morphology. Moreover; the rpfA rpfB double mutant and its 
derivative strain lacking rpfC, rpfA rpfB rpfC displayed a ca. 2-4 log increase 
in susceptibility to erythromycin and vancomycin. Furthermore, unusual colonial 
morphologies with reduced serpentine cording and smooth peripheries were 
observed for these multiple mutants. Cell surface defects and cell distortions 
were evidenced as wrinkle-textured, bent cells and polar tip bulges for the 
abovementioned mutants. The multiple deletion strains also displayed a defect in 
biofilm formation revealing an inability for the mutants to form complex cell-cell 
interactions. Collectively, the data are suggestive of a loss of bacterial cell wall 
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integrity due to rpf gene deletion and it is proposed that rpfA, in combination with 
other genes, is largely responsible for cell wall integrity maintenance. Our data 
indicate that these factors play an important role in cell growth and division and 
therefore represent an untapped source of novel targets for anti-tubercular drug 
discovery.   
 






 
 
 
 
 
 
 
 
 
 
 
 
vii 
 
Acknowledgements 
 
I would like to acknowledge the Almighty in all my ways, for strength and favour; 
nothing would be possible without Him. 
 
Thank you to my family at large; for encouragement, motivation and laughter! 
Mostly, I would love to thank my parents, Sipho Tshabalala and Dieketseng 
Malepe for the support and unconditional love. Through it all, you both were by 
my side in good and bad times. To my loving grandmother, Mary Mapela thank 
you for the support and confidence (in me). To my siblings; Kgomotso, 
Thabang, Khosi, Lungile and Lebogang, thank you for providing comic relief in 
my life- I appreciate your presence. 
 
I am grateful for funding received from NRF (National Research Foundation), 
DST-NRF Centre of Excellence for Biomedical Research and the University of 
the Witwatersrand. 
 
Thank you to the MMU (Microscopy and Microanalysis Unit) at Witwatersrand 
University for affording me the opportunity to work with their scanning electron 
microscope. 
 
To my supervisor, Dr Bavesh Kana, thank you for the guidance and supervision 
throughout the project; I have learnt a lot. 
 
To Dr. Edith Machowski, thank you for generating the necessary vectors for 
completion of the study. 
 
I would like to extend my gratitude to my fellow colleagues and senior staff, at the 
MMRU/CBTBR, for assistance and support- this simplified many challenges.  
 
I would like to thank all my good friends; including Tshepo Nkosi for his 
generosity and kindness and Bongani Malaza for support.    
viii 
 
Table of Contents 

Declaration ....................................................................................................................... iii
Dedication ......................................................................................................................... iv
Abstract .............................................................................................................................. v
Acknowledgements ......................................................................................................... vi
Table of Contents .......................................................................................................... viii
List of Figures ................................................................................................................... x
List of Tables ................................................................................................................... xii
Nomenclature ................................................................................................................. xiii
1. Introduction ................................................................................................................... 1
1.1 Tuberculosis chemotherapy ................................................................................. 1
1.2 Drug resistance, HIV coinfection and vaccination ............................................ 3
1.3 M. tuberculosis pathogenesis and latent TB infection ..................................... 5
1.4 Resuscitation promoting factors .......................................................................... 8
1.4.1 Micrococcus luteus Rpf ................................................................................. 9
1.4.2 Mycobacterial rpf-like genes ....................................................................... 10
1.4.3 Rpf domain .................................................................................................... 12
1.4.4. Muralytic activity .......................................................................................... 12
1.4.5 The peptidoglycan ........................................................................................ 21
1.4.6 Biological roles of Rpfs in M. tuberculosis ................................................ 25
1.5 Aims of this study................................................................................................. 30
2.  Materials and Methods............................................................................................. 31
2.1 Bacterial strains and growth conditions ........................................................... 31
2.2 General laboratory techniques .......................................................................... 31
2.2.1 DNA isolation ................................................................................................ 31
2.2.2 DNA manipulation ........................................................................................ 36
2.2.3 DNA precipitation ......................................................................................... 37
2.2.4 Gel electrophoresis ...................................................................................... 38
2.2.5 Gel extraction and purification .................................................................... 38
2.2.6 DNA quantification ....................................................................................... 39
2.2.7 Preparation of E. coli DH5 competent cells using rubidium chloride . 39
2.2.8 PCR screening of E. coli transformants .................................................... 40
2.2.9 Serial dilutions .............................................................................................. 40
2.2.10 DNA sequencing ........................................................................................ 41
2.3 Bioinformatics analysis of rpf genes in M. smegmatis ................................... 41
2.4 Construction of rpf-knockout mutants .............................................................. 41
2.4.1 Polymerase Chain Reaction (PCR) ........................................................... 42
2.4.2 Construction of knockout vectors for rpfA and rpfB ................................ 43
2.4.3 M. smegmatis mc2155 competent cells preparation ............................... 46
2.4.4 Screening for M. smegmatis rpf deletion mutants by PCR .................... 47
2.4.5 Southern blot analysis ................................................................................. 48
2.5 Growth kinetics..................................................................................................... 51
2.6 Drug susceptibility assay .................................................................................... 52
2.7 Analysis of changes in colony morphology ..................................................... 52
2.8 Anaylsis of biofilm formation .............................................................................. 52
ix 
 
2.9 Analysis of cell morphology by scanning electron microscopy .................... 53
3. Results ......................................................................................................................... 54
3.1 Bioinformatics analysis of rpf-like genes in M. smegmatis ........................... 54
3.1.1 M. smegmatis Rpf-like proteins are secreted signal peptides .............. 58
3.2 Construction of mutants defective for one or more rpf genes ...................... 61
3.2.1 Suicide delivery vector construction .......................................................... 63
3.2.2 Construction of single deletion mutants of M. smegmatis defective for 
rpfA and rpfB ........................................................................................................... 85
3.2.3 Construction of double and triple mutants of M. smegmatis defective 
for multiple rpf-like genes. ..................................................................................... 89
3.3 Southern blot analysis of mutant strains to further confirm genotype ......... 93
3.4 Construction of complemented derivatives ..................................................... 96
3.5 Phenotypic characterization of the rpf single and multiple mutants ............ 97
3.5.1 Growth kinetics of the single and multiple rpf mutants ........................... 97
3.5.2 Bacterial clumping in liquid culture associated with rpfA gene deletion
................................................................................................................................... 99
3.5.3 The multiple rpf deletion mutants display an increase in susceptibility to 
erythromycin and vancomycin ............................................................................ 101
3.5.4 Deletion of multiple rpf genes results in alterations in colony 
morphology. .......................................................................................................... 106
3.5.5 Biofilm formation defects associated with multiple rpf gene deletions
................................................................................................................................. 108
3.5.6 Cell morphological deformities resulting from multiple rpf deletion .... 110
4. Discussion ................................................................................................................. 113
4.1 Concluding remarks .......................................................................................... 121
5. Appendices ............................................................................................................... 123
5.1 Appendix A: Culture media .............................................................................. 123
5.2 Appendix B: Solutions ....................................................................................... 124
5.3 Appendix C: Plasmids and molecular weight markers ................................ 125
6. References ................................................................................................................ 127
 

x 
 
List of Figures 
 
Figure 1: A schematic representation of the M. tuberculosis Rpf-like proteins 
showing the presence and positioning of the common Rpf domain ...................... 11 
Figure 2: Crystal structure of DUFRpfB consisting of two distinct domains: 
catalytic and G5 domains .............................................................................................. 15 
Figure 3: The crystal structure of RipA catalytic domain showing the residues 
involved in catalysis particularly; cysteine383, histidine432 and glutamine444 ... 18 
Figure 4: The peptidoglycan layer within the mycobacterial cell wall .................... 22 
Figure 5: Peptidoglycan biosynthesis is initiated with the production of 
peptidoglycan precursors in the cytoplasm and transported to the periplasm by a 
possible “flippase”; where transglycosylation (TG) and transpeptidation (TP) 
reactions occur forming the peptidoglycan sacculus ................................................ 23 
Figure 6: Cleavage sites within the peptidoglycan resulting in degradation of the 
murein by hydrolases. Ami, N-acetylmuramyl-L-alanine amidase; LD/DD- EPase, 
LD/DD-endopeptidase; LD/DD-CPase, LD/DD-carboxypeptidase ........................ 24 
Figure 7: A schematic representation of the genomic organization of rpf-like 
genes in M. smegmatis (M. smeg) compared to rpf-like genes of M. tuberculosis 
(TB). .................................................................................................................................. 54 
Figure 8: Comparative amino acid sequence alignment of the Rpf proteins in M. 
smegmatis and M. tuberculosis ................................................................................... 57 
Figure 9: Signal peptide prediction and localization of signal peptide cleavage 
sites within the M. smegmatis Rpf-like protein sequences. ..................................... 60 
Figure 10: A schematic representation of the rpf regions amplified during PCR 
with specifically designed primers, and the resulting PCR fragments with 
expected sizes. ............................................................................................................... 63 
Figure 11: PCR fragments amplified for rpfA. (A+B) Thermus aquaticus (Taq) 
PCR .................................................................................................................................. 64 
Figure 12: PCR fragments amplified for rpfB homologous regions ........................ 66 
Figure 13: pBluescript carrier plasmid vector linearized with SmaI enzyme. ....... 68 
Figure 14: rpfA and rpfB constructs digested with appropriate enzymes releasing 
the cloned insert. ............................................................................................................ 70 
Figure 15: Schematic showing three-way cloning resulting in simultaneous 
ligation of upstream and downstream homologous regions to p2NIL knockout 
vector by directional cloning. ........................................................................................ 71 
Figure 16: p2NIL plasmid vector digested with appropriate enzymes for cloning 
purposes.. ........................................................................................................................ 72 
Figure 17: Upstream and downstream homologous rpf fragments digested from 
replicating vectors. ......................................................................................................... 73 
Figure 18: Restriction mapping of the pNRPFA construct shown alongside its 
map ................................................................................................................................... 74 
Figure 19: pNRPFB restriction mapping .................................................................. 76 
Figure 20: PacI linearized pNRPFA and pNRPFB constructs. .......................... 77 
Figure 21: PacI cassette isolation from pGOAL19 plasmid vector ......................... 78 
xi 
 
Figure 22: pSVRPFA restricted with various enzymes for confirmation of suicide 
vector integrity. Suicide delivery vector map shown alongside restriction mapping
........................................................................................................................................... 79 
Figure 23: Restriction mapping of pSVRPFB for plasmid integrity confirmation.
........................................................................................................................................... 81 
Figure 24: pGEM plasmid vector restricted with appropriate enzymes in 
preparation for three-way cloning ................................................................................ 82 
Figure 25: Restriction mapping of pGRPFA construct shown alongside the 
knockout construct map. ............................................................................................... 83 
Figure 26: pGRPFB restriction mapping shown with the construct map ............ 84 
Figure 27: Construction of knockout mutants by two step allelic exchange 
mutagenesis. ................................................................................................................... 86 
Figure 28: Illustration of the screening process and identification of rpfA mutants 
using rpfA allelic-specific screening primers following allelic exchange 
mutagenesis .................................................................................................................... 87 
Figure 29: The identification of rpfB mutants resulting from the demonstrated 
screening strategy using rpfB allelic-specific screening primers, following allelic 
exchange mutagenesis ................................................................................................. 89 
Figure 30: Identification of rpfA rpfB double mutants with the use of rpfB 
allelic-specific screening primers in a rpfA genetic background, following allelic 
exchange mutagenesis.. ............................................................................................... 90 
Figure 31: The identification of rpfC and rpfE deficient genomic DNA in the rpfA 
rpfB double mutant genetic background using rpfC and rpfE allelic-specific 
primers following allelic exchange mutagenesis ....................................................... 92 
Figure 32: Genotyping of the upstream and/or downstream regions of the rpf 
mutants by Southern blot analysis .............................................................................. 96 
Figure 33: Growth characteristics of wild type in comparison to the rpf mutants 
and a complemented derivative ................................................................................... 98 
Figure 34: Culture flasks showing bacterial clumping in 33-hour stationery phase 
cultures of single rpfA and multiple rpf mutants lacking an rpfA gene .............. 100 
Figure 35: Drug and detergent susceptibility testing of the wild type, rpf mutants 
and a complemented derivative ................................................................................. 104 
Figure 36: Colony morphological changes as a result of successive rpf gene 
deletion. ......................................................................................................................... 108 
Figure 37: Retarded biofilm formation in multiple rpf mutants .............................. 109 
Figure 38: High magnification Scanning Electron Microscopy images showing cell 
morphological defects associated with rpfA gene loss .......................................... 112 
 
 
 
 
 
 
 
 
xii 
 
List of Tables 

Table 1: Strains and plasmids used in this study ...................................................... 32 
Table 2: Oligonucleotide sequences used in the construction of rpf knockout 
strains in M. smegmatis. Bold bases represent engineered restriction enzyme 
recognition sequences for cloning purposes ............................................................. 44 
Table 3: Allelic-specific oligonucleotide sequences used in this study for rpf 
deletion mutant DNA screening. F and R represent forward and reverse primers 
respectively. .................................................................................................................... 49 
Table 4: Restriction mapping for pNRPFA .............................................................. 74 
Table 5: pNRPFB restriction mapping ...................................................................... 75 
Table 6: Restriction mapping of rpfA suicide vector (pSVRPFA) ...................... 79 
Table 7: rpfB suicide vector (pSVRPFB) restriction mapping. ........................... 80 
Table 8: Mapping of pGRPFA construct by restriction digestion. ........................ 82 
Table 9: pGRPFB restriction mapping ...................................................................... 84  
 
xiii 
 
Nomenclature 
 
AAP                       Antarctic Alkaline Phosphatase 
Amp                       Ampicillin 
bp                          Base pairs 
CFU                      Colony forming unit 
CSPD                    Disodium 2-chloro-5-(4-methoxyspiro (2-dioxetane-3,2 (2-                  
                             dioxetane-3,2-(5’-chloro)-tricyclo[3.3.1.1.3,7.]decan)-.4-yl)-1- 
                             phenyl phosphate 
CTAB                   Cetyltrimethylammonium bromide 
DCO                     Double cross over 
DIG                      Digoxigenin 
DNA                     Deoxyribonucleic acid 
dNTP                   Deoxynucleotide triphosphate 
DOTS                  Directly Observed Therapy – Short Course 
EDTA                   Ethylenediaminetetraacetic acid 
Emb                     Ethambutol 
FIB                       Focused ion beam 
g                          gram 
hr                         Hours 
HCl                      Hydrochloric acid 
HIV                      Human Immunodeficiency Virus 
hyg                     Gene encoding hygromycin B resistance 
Hyg                     Hygromycin 
Inh                      Isoniazid 
kb                        Kilo base pair 
Km                       Kanamycin 
LA                        Luria-Bertani agar 
lacZ                     Gene encoding -galactosidase 
LB                        Luria-Bertani broth 
LTBI                     Latent tuberculosis infection  
xiv 
 
MDR-TB              Multidrug-Resistant Tuberculosis 
min                      Minutes 
ml                        Millilitre 
MOPS                 3-(N-morpholino)propane sulphonic acid 
NaCl                    Sodium chloride 
NAG                    N-acetylglucosamine 
NAM                    N-acetylmuramic acid 
NaNO2                 Sodium nitrite 
NaOH                  Sodium hydroxide 
OD600                  Optical density at 600 nanometre wavelength 
PCR                    Polymerase Chain Reaction 
PG                      Peptidoglycan 
Pza                     Pyrazinamide 
R                        Resistant 
Rif                      Rifampin 
Rpf                     Resuscitation promoting factor 
rpm                     Revolutions per minute 
sacB                   Gene encoding levansucrase 
SCO                    Single cross over 
sdH2O                 Sterile distilled water 
SDS                    Sodium dodecylsulphate 
SEM                    Scanning electron microscopy 
Suc                     Sucrose 
TB                      Tuberculosis 
TE                      Tris-EDTA 
TG                     Transglycosylation 
TP                      Transpeptidation 
Tris                    Tris(hydroxymethyl)aminomethane 
Tween                Polyoxyethylene sorbitan monooleate 
VBNC                 Viable but non-culturable 
v/v                      Volume per volume 
xv 
 
w/v                     Weight per volume 
WHO                  World Health Organization 
XDR-TB             Extensively Drug Resistant Tuberculosis  
X-gal                  5-bromo-4-chloro-3-indolyl--D-thiogalactopyranoside                
1 
 
1. Introduction 
 
Mycobacterium tuberculosis, the causative agent of tuberculosis (TB) is a 
formidable human pathogen that has infected one third of the world’s population 
and continues to cause an astounding 9.27 million new cases of TB and 1.3 
million deaths annually (WHO, 2009), despite the availability of a vaccine and a 
chemotherapeutic regimen. The situation is further exacerbated by the presence 
of multi-drug (MDR-TB) and extensively-drug resistant (XDR-TB) strains, with 
estimated figures of MDR-TB cases reaching 0.5 million (WHO, 2009). The 
majority of the top 15 countries burdened with TB incident cases are African 
countries, an observation thought to be due to the HIV pandemic resulting in 
increased rates of HIV co-infection (WHO, 2009). It is estimated that 15% of the 
total TB incident cases are individuals who are co-infected with HIV (WHO, 
2009).   
1.1 Tuberculosis chemotherapy  
 
Several decades ago, TB was initially treated using monotherapy with isoniazid 
(INH), streptomycin or pyrazinamide (PZA) which proved effective until the rise of 
resistant strains. Fortunately, the idea of multi-drug therapy came to the aid of 
the resistance problem and this form of therapy became standard for the 
treatment of TB (Hall, et al., 2009). Currently TB therapy consists of two phases; 
an initial, intensive component, followed by a variable continuation phase, where 
the duration of the former is two months and a minimum of four months for the 
latter, depending on drug resistance profile (American Thoracic Society, 2003). 
There are a few alterations to the abovementioned conventional regimen in both 
the duration and drug combination of treatment due to varying circumstances 
presented by patients. In the initial phase; rifampin (RIF), ethambutol (EMB), INH 
and PZA are administered daily. Therapy then proceeds with RIF and INH only, 
administered thrice weekly for the final phase (American Thoracic Society, 2003). 
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This course pertains to adult, untreated TB, with patients that have drug 
susceptible strains (American Thoracic Society, 2003).  
 
A hypothesis has been formulated from both in vitro and in vivo observations that 
a heterogeneous population of M. tuberculosis exists in infection and/or in culture 
consisting of actively- , slowly- and non-replicating bacilli (Mitchison, 1979). Their 
data suggests that active growth is seen for bacilli that establish an infection in a 
location where the organism has access to oxygen, in most cases the upper 
lobes of the lung, slower growth is observed in locations such as closed lesions 
under hypoxic and/or acidic conditions. They postulate that INH targets the 
actively-replicating population but is ineffective against the slow-growing cells; 
RIF is also bactericidal against the actively growing cells but is more potent than 
INH. PZA unlike INH and RIF targets both the actively- and slowly-replicating 
cells but is active in an acidic environment (Mitchison, 1979). Thus multidrug-
therapy is imperative for treatment of TB. Unfortunately no drug(s) exists, as yet, 
that target the dormant population (Mitchison, 1979). Dormancy is a reversible 
state of low metabolic activity, in which bacterial cells have the inability to 
proliferate and hence are non-culturable without an intervening resuscitation 
stage (Kell & Young, 2000).  
 
A more recent similar study in E. coli demonstrated the existence of this 
heterogeneous population and the phenomenon, bacterial persistence 
(Balaban, et al., 2004). Bacterial persistence is the ability of cells to survive 
strong doses of antibiotic treatment thus revealing an inherent heterogeneity 
within the population, characterized by differing growth rates (Balaban, et al., 
2004). The authors’ work carried out in wild type and high persistence (hip) 
mutant, hipA7 and hipQ, cells showed that a few unusual cells survive and 
continue dividing following ampicillin treatment. The hipA gene has been 
implicated in high frequencies of persistence, toxicity and cold sensitivity. 
Mutations within the gene produce persisters at a significantly higher frequency 
(Korch, et al., 2003).  These were defined as persister cells and were identified to 
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exhibit diminished growth rates in contrast to the majority of the population prior 
to antibiotic exposure. Thus both hipA7 and hipQ populations consist of two 
distinguishable subpopulations, normal cells and persisters, with differing growth 
rates. The persisters display the ability to assume normal fast growth thereby 
producing an ampicillin-sensitive population (Balaban, et al., 2004).  
Observations from the hipA7 and hipQ data led to the definitions of Type I and 
Type II persisters respectively. The hipA7 persisters originate from stationary 
phase in an arrested growth state, while hipQ persisters are continuously slowly 
replicating and are not generated in stationary phase (Balaban, et al., 2004). The 
E. coli wild type population constitutes three subpopulations; normal cells, type I 
and type II persisters (Balaban, et al., 2004)- a similar situation described above 
for an M. tuberculosis population by (Mitchison, 1979). Persistence in bacteria is 
a mechanism of survival in changing environments and stress, such as antibiotic 
treatment (Balaban, et al., 2004) - a mechanism which seems to be used by M. 
tuberculosis.  
  
1.2 Drug resistance, HIV coinfection and vaccination  
 
As mentioned earlier, World Health Organization (WHO) reported 0.5 million 
cases of MDR-TB in 2007 (WHO, 2009) and a minimum of one XDR-TB case in 
57 countries by the end of 2009 (WHO, 2009). MDR-TB is defined as the 
resistance to first line drugs; particularly RIF and INH while XDR-TB is MDR-TB 
with additional resistance to any fluoroquinolone and either capreomycin, 
amikacin or kanamycin (Raviglione & Smith, 2007). The emergence of these 
forms of drug resistant M. tuberculosis strains is indicative of poor tuberculosis 
control within the health care system as these strains arise due to poor 
diagnosis, incorrect treatment, drug toxicity (American Thoracic Society, 2003, 
Singla, et al., 2010) and patient non-compliance resulting in transmission to other 
individuals (Raviglione & Smith, 2007). A hindrance to the efficient identification 
and treatment of these strains is the lack of appropriate infrastructure, which 
includes laboratory capacity for culturing organisms (WHO, 2009). DOTS
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(Directly Observed Treatment, Short-course) has been implemented globally in 
an attempt to manage the TB crisis by the identification of individuals with active 
disease and supervision of patients during treatment thus ensuring completion of 
treatment. Statistics have indicated that the programme has improved 
management of the TB crisis in many countries (WHO, 2006). 
 
Bronchoalveolar antigen-specific CD4+ T cells that are elicited due to the 
presence of bacterial or viral respiratory infections are defective in HIV+ 
individuals and this fact may play a role in the individuals being prone to TB 
(Jambo, et al., 2011). It has been hypothesized that HIV exacerbates TB due to 
increased HIV replication at areas where M. tuberculosis infection has occurred 
thus this results in poor control of bacterial growth within the granulomas 
(Diedrich & Flynn, 2011).   
 
Currently, the vaccine used to prevent TB is the Bacillus Calmette-Guerin (BCG) 
which was developed in 1908 and is essentially an attenuated form of 
Mycobacterium bovis. The vaccine is administered to infants in several countries 
around the globe and has been shown to offer between 67%-79% protection 
against TB meningitis and 58%-87% protection against miliary disease in young 
children (Swaminathan & Rekha, 2010). Experimental and observational studies 
have shown that the BCG vaccine affords 26% and 61% protection against 
leprosy respectively, although the protective efficacy was overestimated for the 
latter (Setia, et al., 2006). Repeated vaccination, as opposed to single dose, 
resulted in increased protective efficacy against leprosy (Setia, et al., 2006); up 
to 50% in Malawi (Karonga, 1996). This vaccine has proven to be inconsistent 
and controversial over the years more especially since the rising incidence of HIV 
infection. Reports have shown that the vaccine caused disseminated BCG 
disease in South African infants infected with HIV (Hesseling, et al., 2009) and it 
also triggered Lupus vulgaris, a form of cutaneous TB in a child (Najem, et al., 
2009). An improved BCG vaccine or a novel TB vaccine would thus be critical to 
prevent TB.  
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1.3 M. tuberculosis pathogenesis and latent TB infection 
 
Individuals presenting with active pulmonary TB are the most infectious within a 
shared space however is it important to note that not all individuals exposed to 
M. tuberculosis develop an infection and furthermore, not all of those infected 
develop active disease. The infection cycle begins with exposure to droplet nuclei 
originating from the chest and/or lungs of infected individuals during coughing. 
The route of infection is through inhalation of the 1-5 m nuclei consisting of M. 
tuberculosis cells but successful transmission and type of infection is determined 
by various factors including; host and pathogen factors, concentration of inhaled 
nuclei and the duration of exposure (Dheda, et al., 2010). Upon exposure; 
approximately 50-70% of individuals may rid the system of the infection by either 
innate or adaptive immunity, while the remaining will develop an infection. Of the 
infected individuals, 95% contain the infection in the form of latent TB infection 
(LTBI), and pose a possible risk of reactivation later in life, whereas the 
remaining 5% will present with active disease (Dheda, et al., 2010).   
 
The miniature droplet nuclei pose a size advantage which permits the M. 
tuberculosis cells to escape bronchi defenses and migrate into the alveoli where 
phagocytosis occurs via alveolar macrophages, dendritic cells, neutrophils and 
epithelial cells (Ahmad, 2010). Within the phagocytotic cells, the bacilli replicate 
intracellularly and are disseminated, mostly in dendritic cells, to the lymph nodes. 
Thus the phagocytotic cells act as protection from the host immune system and 
as a means of transport to other sites, which is a remarkable mechanism the 
tubercle bacilli have adopted. After infection, bacteria begin to grow within 
macrophages at the site of infections. It is only at this stage that the host 
adaptive immunity takes charge 2-8 weeks post-infection and replication of the 
bacilli is halted through the activation of cell-mediated immunity. The alveolar 
macrophages secrete inflammatory chemical signals indicating the presence of 
infecting organisms; as a result other cells of the immune system (T-
lymphocytes, monocytes and neutrophils) move towards the site of infection to 
6 
 
destroy cells infected with the tubercle baclli but fail to completely eradicate all 
bacterial cells (Dheda, et al., 2010). The macrophages alike are unsuccessful in 
the eradication of the tubercle bacilli and this ultimately leads to macrophage 
necrosis. The destruction of the macrophages results in the release of bacterial 
cells that then infect other cells and the cycle of phagocytosis is repeated. The 
fully developed dendritic cells containing the tubercle bacilli disseminate to the 
lymph nodes where the CD4+ and CD8+ T cells are primed. The primed T cells 
together with fibroblasts, stromal cells, dendritic cells, epithelioid macrophages, 
multinucleated giant cells and endothelial cells are directed to the site of infection 
where they form granulomas. The granulomas restrict dissemination of bacteria 
to other areas of the lung (Saunders & Britton, 2007, Dutta, et al., 2010). 
Interferon- (IFN-) released by CD4+ cells identify macrophages that present 
antigens against the tubercle bacilli at their surface and destroy these cells. This 
is evidenced by the presence of granulomatous lesions and dispersed 
hemorrhages marked by discoloured, purple areas on the lung surface (Dutta, et 
al., 2010).   
 
With LTBI, some M. tuberculosis cells evade the host immune responses and 
remain within granulomas for prolonged periods (Tufariello, et al., 2003, 
Saunders & Britton, 2007). An individual who appears healthy but presents with 
delayed-type hypersensitivity reaction to purified protein derivative (PPD), 
mycobacterial antigens, is presumed to be latently infected (Jafri, et al., 2011). A 
more potent T-cell response is elicited in LTBI against antigens that are 
associated with latency (Tully, et al., 2005, Schuck, et al., 2009). It has been 
demonstrated that CD8+ T cells do not play a role in acute infection but rather in 
latent infection where the production of IFN- is observed. Furthermore, depletion 
of CD8+ T cells and IFN- during latent infection permits for a higher bacterial 
load in the lungs of M. tuberculosis-infected mice while no differences are 
observed in acute infection (van Pinxteren, et al., 2000).     
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LTBI can be defined as an asymptomatic state lacking clinical or radiological 
signs of disease but is characterized by the presence of viable tubercle bacilli 
within the host (Dheda, et al., 2010). This definition can be mirrored with the 
microbiological phenomenon of in vitro bacterial dormancy where these cells are 
said to be viable but non-culturable (VBNC) (Shleeva, et al., 2002).  The subject 
of latency is confounding and controversial in the TB literature as was previously 
observed in the case of Human Immunodeficiency Virus-1 (HIV-1). It is proposed 
that there are different responses to TB infection: innate and acquired immunity, 
and the degree of these responses vary with latent and active infection (Young, 
et al., 2009). Latent infection is a consequence of an equilibrium between the 
host and pathogen factors resulting in controlled infection; in other words the 
bacilli are thought to be viable but are not actively dividing, although no evidence 
exists to support the idea (Young, et al., 2009). It has long been hypothesized 
that LTBI is characterized by the presence of bacteria in a non-replicating or 
dormant-like state however, this has been challenged recently. A key finding in 
this regard is the observation that chronic, stationary infection in mice is 
characterized by bacilli that are continuously replicating albeit at a reduced rate 
(Gill, et al., 2009); suggesting that latent infection may be characterized by a 
dynamic population of cells. However, it is important to note in this regard that 
the mouse is a poor model of latent TB infection.     
 
LTBI poses a huge public health threat in the global burden of active TB thus it is 
a priority to comprehend the biology of M. tuberculosis during LTBI in order to 
develop interventions that target this form of infection. Critical in this regard are 
the factors responsible in the revival of dormant bacteria, more especially M. 
tuberculosis, in vitro and the best studied thus far is the Resuscitation Promoting 
Factor (Rpf) (Mukamolova, et al., 1998, Shleeva, et al., 2002). The question is 
“Do Rpfs have roles in human tuberculosis infection?” Indeed it has been shown 
that the vast majority of M. tuberculosis cells in smear-positive sputa are 
revealed only by the addition of Rpfs (Mukamolova, et al., 2010), therefore this 
confirms that these factors do play an important role in human infection. They 
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also represent an untapped source of novel targets for anti-tubercular drug 
discovery as demonstrated by the identification of 2-nitrophenylthiocyanates 
(NPT) compounds which inhibit Rpf function (Demina, et al., 2009). 
 
1.4 Resuscitation promoting factors 
 
Rpf is a protein first identified in Micrococcus luteus; a non-sporulating, Gram-
positive bacterium (Mukamolova, et al., 1998). This secreted 16-17 kDa protein 
was shown to stimulate the growth of both actively replicating and dormant Mi. 
luteus cells; furthermore it was responsible in the reduction of the apparent lag 
phase of the same bacterial cells (Mukamolova, et al., 1998, Mukamolova, et al., 
1999). Moreover growth stimulation and revival by purified, recombinant Rpf, 
from Mi luteus was also observed with different mycobacterial species including 
M. tuberculosis, Mycobacterium avium, Mycobacterium kansasii, Mycobacterium 
bovis and Mycobacterium smegmatis (Mukamolova, et al., 1998, Biketov, et al., 
2000, Shleeva, et al., 2002, Shleeva, et al., 2004). It has been suggested that 
this protein has properties of both autocrine and paracrine signaling molecules 
and has thus been termed a “bacterial cytokine” (Mukamolova, et al., 1998). A 
search of rpf homologues in other bacteria demonstrated that rpf genes are 
present in many diverse actinobacteria, with some bacteria encoding multiple 
homologues (Mukamolova, et al., 1998, Mukamolova, et al., 2002, Ravagnani, et 
al., 2005, Schroeckh & Martin, 2006).  
 
In Corynebacterium glutamicum two rpf-like homologues, rpf1 and rpf2 have 
been identified and the gene products are secreted as evidenced by the 
presence of leader peptides. It has also been demonstrated that one of these, 
Rpf2, is glycosylated by a specific pmt-encoded glycosyl transferase (Manhe et 
al., 2006). Both proteins have in common the rpf domain which shares homology 
to that of Mi. luteus, this domain is positioned at the N- and C-terminus in Rpf1 
and Rpf2 respectively (Hartmann, et al., 2004). It has been demonstrated that 
both genes can be deleted from the genome of C. glutamicum without abrogation 
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of growth indicating that they are not essential for viability unlike the essentiality 
of the single rpf gene in Mi. luteus (Mukamolova, et al., 2002). Interestingly, the 
cell surface associated Rpf2 has three conformational forms of different sizes 
(Hartmann, et al., 2004) but these forms are not distinguished by glycosylation as 
previously thought (Mahne, et al., 2006). The rpf1, rpf2 double mutant (MH28) 
displays a growth defect in vitro and the phenotype was reversed by the 
simultaneous addition of both genes in the mutant background implying that the 
observed defect was due to loss of both rpf genes (Hartmann, et al., 2004).    
  
Salmonella typhimurium LT2 also encodes an rpf homologue, it has been 
demonstrated that the recombinant Rpf of this organism has the ability to reverse 
the VBNC (viable but non-culturable) state of S. oranienburg cells to a culturable 
state by recombinant Rpf supplementation to growth media (Panutdaporn, et al., 
2006). However, the Rpf does not possess hydrolytic activity like all Rpf-like 
proteins therefore it may not represent true Rpf (Kana & Mizrahi, 2009). 
  
1.4.1 Micrococcus luteus Rpf 
 
Contrary to what was previously thought; the genome sequence of Mi luteus 
revealed that only a single copy of the rpf gene exists in Mi. luteus which is 
located within a monocistronic operon (Mukamolova, et al., 1998, Mukamolova, 
et al., 2002). In vitro assays have shown that rpf transcription commences very 
early during bacterial growth and copious transcripts are detected during the lag 
phase (Mukamolova, et al., 2002). A massive decrease in transcript level is 
observed during mid-log phase until none can be detected in late stationery 
phase. The presence of Rpf in culture supernatants is delayed in relation to these 
transcriptional changes and the protein is possibly secreted in different 
conformational forms (Mukamolova, et al., 2002, Hartmann, et al., 2004, Mahne, 
et al., 2006). It has been reported that Rpf from environmental Mi. luteus strains 
is present in culture supernatants at low concentrations probably due to the 
altered structure of the protein, where the linker region that connects the protein 
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to the LysM domain is extended, resulting in an inability of the protein to be 
secreted into the medium, thus tethering it rather tightly to the cell wall (Koltunov, 
et al., 2010). Rpf molecules are located on the surface of bacterial cells 
(Mukamolova, et al., 1998, Mukamolova, et al., 2002) and this is the most likely 
reason the accumulation of Rpf in culture supernatants is observed possibly 
explaining the disconnect between extracellular abundance and transcription 
(Mukamolova, et al., 1998, Mukamolova, et al., 2002).  
 
1.4.2 Mycobacterial rpf-like genes    
 
M. tuberculosis and M. bovis encode five Rpf-like genes, designated rpfA-E 
whereas two, possibly three (Kana & Mizrahi, 2009), have been uncovered in M. 
leprae and four in M. smegmatis (Mukamolova, et al., 1998). Like M. smegmatis; 
rpfA-C and rpfE homologues are present in M. ulcerans, M. avium and M. 
marinum genomes (Kana & Mizrahi, 2009). The products of all five M. 
tuberculosis rpf-like genes have in common a conserved ca. 70 amino acid 
containing domain, termed the Rpf domain which shares high homology with a 
similar domain from Mi. luteus Rpf, Figure 1. All five proteins have predicted 
leader sequences suggesting that they are transported to the cell wall for 
secretion (Mukamolova, et al., 1998, Mukamolova, et al., 2002, Zhu, et al., 2003). 
The Rpf-like domain of RpfA is followed by a large region of proline + alanine-rich 
repeats (Figure 1) consisting of APADLAPP as the consensus sequence. RpfB is 
the only lipoprotein predicted to be membrane bound since it consists of a 
prokaryotic membrane lipoprotein lipid adherence site situated at its N-terminus, 
thus it is the only cell-wall associated Rpf (Mukamolova, et al., 2002, Rezwan, et 
al., 2007). The Rpf-like domains of all the proteins, excluding RpfA, in M. 
tuberculosis are positioned c-terminally (Mukamolova, et al., 2002). The 
biological activities of the M. tuberculosis recombinant Rpfs have been tested in 
vitro and cause a reduction in the apparent lag phase of M. tuberculosis (Zhu, et 
al., 2003), Mi. luteus and M. smegmatis (Mukamolova, et al., 2002).  
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Figure 1: A schematic representation of the M. tuberculosis Rpf-like proteins showing 
the presence and positioning of the common Rpf domain [adapted from (Mukamolova, 
et al., 2002)]. 
 
M. avium subsp. paratuberculosis recombinant Rpf also reduces the lag phase 
and has a growth-stimulatory effect on freeze-dried cells (Wu, et al., 2008) or 
dormant-like, stationary phase cells which was further confirmed by CFU 
quantification (Zhu, et al., 2003). In Mi. luteus culture grown in minimal medium, 
the M. tuberculosis RpfA and RpfC proteins display outstanding (lag phase 
reduction) activity whereas RpfA, RpfC, RpfD and RpfE proteins show 
comparable activity in M. smegmatis culture (Mukamolova, et al., 2002). Activity 
profiles for Rpfs tested show that an optimal concentration range exists, where 
less activity is observed when the range is exceeded or completely abolished 
when it is sub-optimal (Mukamolova, et al., 2002, Zhu, et al., 2003, Koltunov, et 
al., 2010). All five recombinant proteins of M. tuberculosis stimulate the growth of 
M. bovis, and the addition of anti-Rpf antibody suppress growth confirming that 
the Rpf-like proteins are responsible for the growth-stimulatory effect from an 
extracellular location (Mukamolova, et al., 2002). Thus all the M. tuberculosis 
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Rpf-like proteins also stimulate growth of other organisms, which is a property 
shared with Mi. luteus Rpf (Mukamolova, et al., 1998, Mukamolova, et al., 2002).  
 
1.4.3 Rpf domain 
 
As mentioned earlier, all Rpf proteins have in common a conserved ca. 70 amino 
acid region, the Rpf domain (Mukamolova, et al., 1998). The three dimensional  
structure of the mycobacterial Rpf domain is comparable to that of c-type 
lysozyme, moreover there is high sequence conservation over a stretch of 110 
common sequences between Rpf, and eukaryotic c-type and g-type lysozymes 
(Cohen-Gonsaud, et al., 2004). Lysozymes are hydrolytic enzymes which act on 
the peptidoglycan by cleavage of the -(1,4)-glycosidic bond between N-
acetylmuramic acid (NAM) and N-acetylglucosamine (NAG) residues; c-type and 
g-type refer to chicken/conventional type and goose type respectively (Callewaert 
& Michiels, 2010). Structural similarities are conserved between Rpfs and c-type 
lysozymes; which include residues within the catalytic site (catalytic proton donor 
or active site glutamate), the glycine residue which is compulsory structurally and 
residues residing within the saccharide-binding groove (Cohen-Gonsaud, et al., 
2004).  
 
1.4.4. Muralytic activity 
 
Since Rpf possesses a lysozyme-like fold, zymography confirmed that it is 
indeed a muralytic enzyme (Mukamolova, et al., 2006). Other evidence in this 
regard includes the observation, in vitro, that bacterial lysis results from the over-
expression of Rpf in the periplasm of Escherichia coli. In addition, an assay 
displaying hydrolysis of fluorescamine- labeled Mi. luteus cell wall due to the 
activity of recombinant Rpf confirmed that Rpf displays muralytic activity 
(Mukamolova, et al., 2006). Moreover, the ability displayed by the recombinant 
Rpf to hydrolyse 4-methylumbelliferyl--D-N,N’,N’’-triacetylchitotrioside, a 
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synthetic lysozyme substrate, infers that its muralytic activity is comparable to 
that of conventional lysozymes (Mukamolova, et al., 2006, Telkov, et al., 2006). 
In vitro assays demonstrate that the conserved domains found in RpfB (Rv1009), 
RpfC (Rv1884c) and RpfD (Rv2389c)  are alone capable of reviving dormant Mi. 
luteus cultures at low (picomolar) concentrations (Cohen-Gonsaud, et al., 2005). 
This indicates that the muralytic domain can be held accountable for the 
resuscitation activity (Cohen-Gonsaud, et al., 2005).   
 
A glutamate residue (E54) (Mukamolova, et al., 2006) is conserved in the Rpf 
domain structure which is a property also shared with c-type lysozymes (Cohen-
Gonsaud, et al., 2004). Site-directed mutagenesis experiments in Escherichia 
coli indicated that the c-type lysozyme glutamate residue (E35) was essential for 
catalysis (Malcolm, et al., 1989, Callewaert & Michiels, 2010). In light of this 
observation, it was logical to infer that the glutamate residue in Rpf proteins may 
also play a critical role in catalysis. However, E54 isosteric substitutions to 
glutamine, alanine and lysine in Rpf confirm that the glutamate residue is 
significant but certainly not essential for the functioning of Rpf as the muralytic 
activity was still maintained although defects in resuscitation were noted 
(Mukamolova, et al., 2006, Telkov, et al., 2006). The degree to which the 
muralytic activity of Rpf is affected by the isosteric substitutions in the 
abovementioned experiments depended solely on the amino acids tested 
(Mukamolova, et al., 2006, Telkov, et al., 2006). Thus the glutamate residue 
serves as a hallmark feature in Rpf-like proteins. A pair of cysteine residues 
which have been proposed to form a disulphide bridge (Cohen-Gonsaud, et al., 
2004) are highly conserved in Rpf-like proteins and mutation of either one or both 
residues have equally noticeable impacts on muralytic activity but more dramatic 
effects on resuscitation activity are observed when both cysteines are mutated as 
opposed to only one (Mukamolova, et al., 2006, Telkov, et al., 2006). It is 
proposed that the cysteine residues not only play a role in Rpf secondary 
structure stabilization but may also participate in the modulation of Rpf activity 
(Mukamolova, et al., 2006).  
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1.4.4.1 RpfB domain: NMR structure  
 
The NMR domain structure of M. tuberculosis Rv1009, also referred to as RpfBc, 
has been determined (Cohen-Gonsaud, et al., 2005) and it revealed an 
oligosaccharide-binding site cleft exists in the protein, which is also observed in 
c-type lysozymes indicating that RpfBc attaches to polysaccharide (Cohen-
Gonsaud, et al., 2005). Analysis of RpfBc demonstrates that the Rpf domain has 
structural properties of both c-type lysozymes and soluble lytic transglycosidases 
(SLT’s) (Cohen-Gonsaud, et al., 2005). Lytic transglycosylases are bacterial 
enzymes known to cleave the -1,4 glycosidic bonds between N-acetylmuramoyl 
and N-acetylglucosaminyl resulting in the formation of 1,6-anhydromuramoyl end 
product (Holtje, et al., 1975, Heidrich, et al., 2002, Scheurwater, et al., 2008).  
Moreover, experimental data indicate that chemical shift modifications within the 
binding groove occur due to bound RpfBc to N,N’,N’’-triacetylchitotriose implying 
that Rpf serves to cleave oligosaccharides (Cohen-Gonsaud, et al., 2005). 
Hence, it is postulated that this action (oligosaccharide cleavage) results in 
bacterial resuscitation from dormancy; however the mechanism of peptidoglycan 
degradation in Rpfs is unclear and the chemical nature of the resulting products 
are unknown (Cohen-Gonsaud, et al., 2005). Many peptidoglycan-degrading 
enzymes function in complexes with other proteins and it has been proposed that 
Rpfs function together with other PG degrading enzymes (Cohen-Gonsaud, et 
al., 2005).  
 
1.4.4.2 DUFRpfB: Crystal structure
 
The crystal structure of a truncated form of RpfB, DUFRpfB, revealed that it 
consists of a catalytic domain and a G5 domain, assuming a “comma-like 
shape” (Figure 2) (Ruggiero, et al., 2009). The catalytic domain bears a likeness 
to that of the NMR structure (Cohen-Gonsaud, et al., 2005), and as previously 
described, possesses certain properties of c-type lysozymes (Cohen-Gonsaud, 
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et al., 2005). In addition to that, structurally it is comparable to invertebrate- type 
(i-type) lysozymes (Ruggiero, et al., 2009).  
 
The G5 domain presents a unique super-secondary structure consisting of two 
three-stranded -sheets, 1 and 2 (Ruggiero, et al., 2009) which are connected 
by cross-linking strands (Figure 2) (Ruggiero, et al., 2009). The G5 domain 
family, comprising 35 members, was initially observed in the Pfam-B database 
and the G5 refers to the glycine residues that are conserved within the structure 
(Bateman, et al., 2005). The domain is present in various domain designs in 
bacterial proteins that play a role in pathogenesis and antimicrobial resistance; 
furthermore it is generally affiliated with an enzymatic domain (Bateman, et al., 
2005) like the catalytic domain in the case of RpfB (Ruggiero, et al., 2009). It has 
been proposed that it is probable that the G5 domain adheres to N-
acetylglucosamine (NAG), one of two monomers making up the glycan strands of 
the peptidoglycan (Vollmer, et al., 2008), which may facilitate cell wall 
degradation by the catalytic domain in Rpfs (Bateman, et al., 2005).   
 
           
 
Figure 2: Crystal structure of DUFRpfB consisting of two distinct domains: catalytic and 
G5 domains (taken from Ruggiero et al, 2009). 
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In accordance to the name given to the domain, not all five glycine residues are 
conserved in RpfB; only Gly245, Gly269, Gly229, Gly232 and the last one is 
replaced by a serine residue (Ser221). Gly229 and Gly232 are situated within the 
DPGVPG sequence, a sequence comparable to collagen sequence, found in one 
of the cross-linking strands connecting the triple-stranded -sheets (Ruggiero, et 
al., 2009). The two glycine residues function to stabilize the -TH- motif (Figure 
2) and this is the most probable reason they are most conserved (Ruggiero, et 
al., 2009). The lengthy G5 domain is designed in such a way that ample -sheet 
backbone atoms are exposed (Ruggiero, et al., 2009) and this structural property 
has been implicated in protein aggregation and possibly association with the cell 
wall (Srisailam, et al., 2002, Esposito, et al., 2006). In light of the structural 
properties of the G5 domain described above and the fact that it probably binds 
NAG (Bateman, et al., 2005), implies that the domain serves an adherence 
function to the cell surface of bacteria (Ruggiero, et al., 2009). The presence of 
both catalytic and G5 domains in RpfB provides convincing evidence for the 
possible mechanism of action of the protein.  
 
1.4.4.3 Synergistic proteins: RpfB and RipA 
 
It was hypothesized that in light of the Rpf-based reactivation function initially 
observed in Mi. luteus, a second protein which is secreted or surface-associated 
could be present that works in synergy with Rpf (Hett, et al., 2007). Rpf-
interacting protein A (RipA) has been identified by yeast two-hybrid screen 
assay, which showed that it interacts with RpfB and RpfE (Hett, et al., 2007). The 
472 amino-acid protein is encoded by the Rv1477 gene in M. tuberculosis and its 
predicted domain, which is situated at its C-terminus and consists of 105 amino 
acids, shares 40% homology to the p60 protein from Listeria monocytogenes 
(Hett, et al., 2007). It was previously shown that a L. monocytogenes strain 
lacking this gene (p60) displayed atypical cell division (Pilgrim, et al., 2003) and 
furthermore, the absence of autolytic bands in zymograms in the same strain 
provided evidence that p60 protein cleaves the bacterium’s cell wall (Lenz, et al., 
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2003). Thus p60 can be considered a cell wall hydrolase. It has also been 
demonstrated that RipA has the ability to cleave Mi. luteus, M. smegmatis and 
Streptomyces cell wall thus confirming that the protein can degrade 
peptidoglycan (Hett, et al., 2007, Hett, et al., 2008). The peptidoglycan, also 
referred to as murein, is a large complex molecule that envelopes the 
cytoplasmic membrane and is defined by glycan strands inter-connected by small 
peptides. It provides protection from cell rupture due to turgor pressure (Vollmer 
& Bertsche, 2008). RipA can therefore also be regarded a hydrolase or an 
endopeptidase (Hett, et al., 2007) like the p60 protein. 
 
1.4.4.4 RipA263-472: Crystal structure 
 
RipA consists of four defined areas according to its sequence analysis; the N-
terminal signal sequence, the predicted NlpC/P60 catalytic domain positioned at 
its C-terminus and two as yet uncharacterized domains, PB07342 and PB015164 
(Hett, et al., 2007, Ruggiero, et al., 2010). Recombinant forms of RipA were 
constructed; one lacking the signal sequence (RipA40-472), the other consisting 
only of the predicted catalytic domain and PB015164 (RipA263-472) and the last 
retaining only the catalytic domain (RipA332-472) (Ruggiero, et al., 2010). The 
crystal structure of RipA263-472 reveals a very close association between the 
catalytic and PB015164 domains; moreover the PB015164 domain forms an 
obstruction over the RipA catalytic site cleft suggesting that RipA is produced in 
an inactive form in a manner akin to zymogens (Ruggiero, et al., 2010). A 
zymogen, also referred to as proenzyme or proprotein, is an inactive form of an 
enzyme that has to undergo biochemical processing in order to mature and 
perform its function (Basak, 2005, Mallorqui-Fernandez, et al., 2008). RipA is 
active as an enzyme only when it is processed; this is evidenced by the in vitro 
observation that RipA332-472 displays the ability to cleave Micrococcus 
lysodeikticus cell wall material whereas RipA263-472 does not (Ruggiero, et al., 
2010).  
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Figure 3: The crystal structure of RipA catalytic domain showing the residues involved in 
catalysis particularly; cysteine383, histidine432 and glutamine444 [Taken from 
(Ruggiero, et al., 2010)].  
 
 
The catalytic domain structure, Figure 3, consists of two  sheet types; the major 
sheet is composed of six  strands arranged in an antiparallel fashion and the 
other, minor sheet has two  strands all connected to six helices (Ruggiero, et 
al., 2010). Three residues; cysteine383, histidine432 and glutamate444, shown in 
Figure 3, are involved in catalysis- an observation atypical of NlpC/P60 domains. 
Substitution of cysteine to alanine abrogates RipA hydrolytic activity thereby 
confirming that cysteine is essential for RipA activity (Ruggiero, et al., 2010). 
RipA therefore belongs to a class of cysteine proteases (Ruggiero, et al., 2010). 
The loop region of the PB015164 domain, is responsible for creating a physical 
barrier across the catalytic cleft making the residues inaccessible for activity 
(Ruggiero, et al., 2010). This prodomain has been shown to be dispensable for 
enzyme folding as observed in vitro from recombinant RipA332-472, thus indicating 
that it serves a regulatory role for catalysis (Ruggiero, et al., 2010). 
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RipA is a secreted protein and like RpfB, it is cell-associated; furthermore it has 
been microscopically demonstrated in M. smegmatis that both proteins localize to 
the septa of replicating cells with the use of red fluorescent protein (RFP) fused 
to the individual proteins (Hett, et al., 2007). As mentioned earlier, RipA was 
identified as a partnering protein for RpfB and experimental evidence- both in 
vivo and in vitro supports the observation (Hett, et al., 2007). RipA-RpfB 
interaction has been proven in vitro by co-precipitation with the use of fusion 
proteins and these proteins were also produced and co-purified in M. smegmatis 
providing evidence for interaction (Hett, et al., 2007). Since the proteins have 
been observed to indeed interact, it was necessary to map the defined area of 
interaction. The RipA C-terminus was identified by yeast three- and two-hybrid 
assays to be the region of interaction and further experiments showed that 25 
amino acids at the C-terminal end are sufficient for interaction (Hett, et al., 2007). 
Moreover, deletion of amino acids within the C-terminus results in weakened 
interaction and deletion of the N-terminus has no effect on interaction confirming 
that the RipA C-terminus is necessary for interaction (Hett, et al., 2007).  
 
1.4.4.5 RipA-RpfB complex: Mechanism of action  
 
As mentioned earlier, RipA and RpfB have been demonstrated to co-localize at 
the septum of dividing cells (Hett, et al., 2007). The above observations may 
indicate the mechanism of action of the synergizing proteins resulting in the 
degradation of peptidoglycan possibly allowing bacteria to exit a state of 
dormancy and consequently in bacterial revival (Hett, et al., 2007).   
              
To comprehend the role that each partnering protein plays in the RipA-RpfB 
complex, an investigation of M. smegmatis strains depleted of ripA and rpfB has 
been undertaken (Hett, et al., 2008). Deletion of the ripA gene (MSMEG_3153) 
proved impossible which indicates that it is an essential gene in M. smegmatis; 
however the knockdown of ripA, under the control of a tetracycline promoter, was 
successful (Hett, et al., 2008). The ripA-depleted strain is growth defective and 
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bacterial clumps are evident in culture, furthermore this strain forms branching 
filaments or chain-like bacteria with the presence of nucleoids and septa at 
intervals along the filament (Hett, et al., 2008). Conversely, the rpfB depleted 
strain displays normal growth and morphology; therefore these observations 
suggest that ripA is important for typical cell division and growth whereas the 
opposite is true for rpfB (Hett, et al., 2008). Reintroducing a copy of the M. 
tuberculosis ripA gene into the ripA-depleted M. smegmatis strain reverses the 
observed phenotype, implying that the biological activities of both M. tuberculosis 
and M. smegmatis RipA proteins are functionally alike. RipA is therefore 
indispensable for the formation of daughter cells arising from cell division (Hett, 
et al., 2008).   
 
The ripA-depleted M. smegmatis strain displays an increased susceptibility to -
lactam drugs, specifically carbenicillin (Hett, et al., 2008), although the molecular 
basis for this increase in susceptibility is unknown. The data suggests that the 
biological activity of RipA is to degrade the peptidoglycan by the hydrolysis of the 
peptide cross-linkages; lack of this activity may change PG structure/stability and 
thus predispose cells to antibiotic activity (Hett, et al., 2008). The proposed 
mechanism of action of RipA and the activity of RpfB provides a synergistic effect 
in the degradation of the peptidoglycan (Hett, et al., 2008).         
 
1.4.4.6 PBP1 and RipA interaction 
 
Further evidence for a peptidoglycan degrading complex of proteins was 
provided by the demonstration that the C-terminus of the mycobacterial 
Penicillin-binding protein 1 (PBP1), which retains the penicillin binding 
transpeptidase domain,  interacts with RipA (Hett, et al., 2010). The interaction 
was confirmed in vivo and in vitro as exemplified by RipA-RpfB interaction. The 
signal sequence and a transglycosylase domain are both positioned at the N-
terminus. Both the penicillin binding transpeptidase and transglycosylase 
domains show homology to Esherichia coli (E. coli) PBP1 (Hett, et al., 2010). 
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PBP1a and PBP1b serve different functions in E. coli; the former is responsible 
for synthesis of the basic framework of the peptidoglycan by the assembly of 
NAM and NAG monomers that build the glycan strands by transglycosylation, 
and catalyzing the reaction by transpeptidation creating cross-linkages between 
stem peptides (Born, et al., 2006, Vollmer & Bertsche, 2008). The latter is 
responsible for synthesis of linear peptidoglycan chains comprising N-
acetylglucosaminyl--1,4-N-acetylmuramoyl-L-Ala--D-Glu-meso-A2pm-D-Ala-D-
Ala or lipid II units (Fraipont, et al., 2006, Vollmer & Bertsche, 2008). They 
therefore have almost similar functions (Born, et al., 2006) and  are bound at the 
cytoplasmic membrane but the catalytic domains are located in the periplasm 
(Born, et al., 2006, Fraipont, et al., 2006, Vollmer & Bertsche, 2008). 
 
It has been proposed that the synergistic hydrolysis rendered by RipA-RpfB 
complex is suppressed by PBP1; however PBP1 does not interfere with RipA 
functioning as observed through in vitro experiments that measure degradation of 
Streptomyces cell wall material by the enzymes, implying that PBP1 plays a 
regulatory role in the function of the RipA-RpfB complex (Hett, et al., 2010). 
Cellular localization studies indicate that PBP1 is not only confined to the septa 
of cells but also to the poles, which makes biological sense since it binds RipA. A 
PBP1-depleted M. smegmatis strain displays growth deficiency which is in line 
with observed morphological alterations and these depleted cells are devoid of 
septa and display bulb-like ends with diminished cell lengths. These data are 
indicative of cell elongation and septation roles served by PBP1 in mycobacteria 
especially since cell wall growth, for this family of bacteria, occurs at the poles 
(Hett, et al., 2010). 
. 
1.4.5 The peptidoglycan      
 
The mycobacterial cell wall consists of two sections; the outer and inner layers 
that enclose the cell membrane (Brennan, 2003).  
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Figure 4: The peptidoglycan layer within the mycobacterial cell wall. [Taken from (Hett & 
Rubin, 2008)]. 
 
 
The cell wall core is composed of the peptidoglycan covalently bonded to the 
arabinogalactan, and mycolic acids thus making up the mycolyl arabinogalactan-
peptidoglycan (mAGP) (Brennan, 2003) or MA-AG-PG complex (MAPc) (Hett & 
Rubin, 2008) as demonstrated in Figure 4. The cell wall core constitutes the inner 
layer, while the outer layer consists of lipids and proteins (Brennan, 2003) 
forming capsule-like material (Hett & Rubin, 2008). Cell wall disturbance results 
in the solubilization of dissociated lipids and proteins (outer section), while the 
inner core remains insoluble. This observation indicates the essentiality of the 
MAPc to bacterial cell viability (Brennan, 2003).   
 
The peptidoglycan, also referred to as murein, is a large complex molecule that 
envelopes the cytoplasmic membrane and is defined by glycan strands inter-
connected through peptide cross-links (Vollmer & Bertsche, 2008).  
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Figure 5: Peptidoglycan biosynthesis is initiated with the production of peptidoglycan 
precursors in the cytoplasm and transported to the periplasm by a possible “flippase”; 
where transglycosylation (TG) and transpeptidation (TP) reactions occur forming the 
peptidoglycan sacculus. [Adapted from (Hett & Rubin, 2008, Kana & Mizrahi, 2009)].  
 
1.4.5.1 Peptidoglycan biosynthesis 
 
Peptidoglycan precursors are synthesized within the cytoplasm and transported 
to the periplasm, where they are cross-linked to form the peptidoglycan sacculus 
(Hett & Rubin, 2008). Synthesis is initiated with the formation of UDP-NAG; 
which is converted to UDP-NAM (muramic acid) by a transferase and reductase, 
MurA and MurB respectively. In mycobacteria, it has been experimentally 
demonstrated that the muramic acid consists of a combination of N-acetyl and N-
glycolyl residues (Mahapatra, et al., 2005). A suite of enzymes catalyze the 
sequential addition of L-alanine, D-glutamine, DAP, and D-alanyl-D-alanine 
amino acids to UDP-NAM as depicted in Figure 5. The UDP-NAM-stem peptide 
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is displaced to a carrier lipid, decaprenyl phosphate (C5o-P) by MurX thus forming 
Lipid I. MurG catalyzes the conversion of Lipid I to Lipid II by a further addition of 
NAG to Lipid I (Hett & Rubin, 2008).  A proposed ‘flippase’ protein is said to exist 
which functions to turn Lipid II from the cytoplasmic side to the periplasmic 
membrane side, although little knowledge is available on the exact mode of 
action (Bouhss, et al., 2008). A further set of reactions occur in the periplasm; 
where a transglycosylase reaction takes place resulting in extension of the 
glycan strand (Hett & Rubin, 2008) by glycosidic linkage (Vollmer & Bertsche, 
2008). Peptide cross-links are formed by a transpeptidase reaction forming 
bonds between the acceptor peptide DAP to either a DAP or the fourth-
positioned D-alanine of the incoming peptide. The terminal D-alanine is released, 
as shown in Figure 5, thereby providing energy for the transpeptidation reaction 
(Hett & Rubin, 2008).    
  
 
 
Figure 6: Cleavage sites within the peptidoglycan resulting in degradation of the murein 
by hydrolases. Ami, N-acetylmuramyl-L-alanine amidase; LD/DD- EPase, LD/DD-
endopeptidase; LD/DD-CPase, LD/DD-carboxypeptidase. Taken from (Kana & Mizrahi, 
2009).  
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1.4.5.2 Peptidoglycan degradation 
 
Degradation of the peptidoglycan results from a host of hydrolases which include; 
amidases, endopeptidases, carboxypeptidases, glycosidases, N-
acetylglucosaminidases, lytic transglycosylases and lysozymes (Vollmer, et al., 
2008) as shown in Figure 6. The N-acetylmuramyl-L-alanine amidases hydrolyse 
the link that joins the peptide stem to the glycan strand by acting on the amide 
bond between the L-alanine residue and NAM, as the name suggests (Vollmer, et 
al., 2008).  The endopeptidases and carboxypeptidases act on the peptide stem; 
cleaving different linkages at different positions within the peptide stem for the 
former, while removing the C-terminally positioned amino acid from the peptide 
stem for the latter. Peptidases also act on amide bonds but the hydrolysis also 
depends on the type of amino acid bond, either between D-amino acids or 
between L- and D-amino acids (Vollmer, et al., 2008). Enzymes that hydrolyze 
the glycan strands act on the -1,4 glycosidic bond between NAM and NAG like 
lysozymes and lytic transglycosylases, although lytic transglycosylases produce 
a 1,6-anhydromuramoyl end product (Holtje, et al., 1975). Similarly, as 
mentioned earlier, the Rpfs are proposed to act on the -1,4 glycosidic bond. The 
synergistic interaction of RipA and RpfB has been established (Hett, et al., 2007) 
but it is speculative that Rpfs may also interact with other peptidases as a 
mechanism for muropeptide signaling (Kana & Mizrahi, 2009).   
 
1.4.6 Biological roles of Rpfs in M. tuberculosis 
 
To discern the biological roles of the five rpf-like genes in M. tuberculosis, gene 
disruptions have been made for each of the rpf homologues by two-step allelic 
exchange mutagenesis and/or specialized phage transduction (Downing, et al., 
2004, Tufariello, et al., 2004). Growth and survival of all the individual rpf mutants 
during logarithmic and stationary phases is comparable to that of the parental 
wild type strain in liquid culture (Downing, et al., 2004, Tufariello, et al., 2004). It 
was noted that the rpfA mutant displays clumping in liquid culture when this 
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gene was deleted in the H37Rv background (Downing, et al., 2004). Hence, all 
five rpf-like genes are individually not required for survival in M. tuberculosis 
(Downing, et al., 2004, Tufariello, et al., 2004). The colony morphology of four of 
the five single mutants is comparable to that of the wild type however, the rpfB 
mutant (Rv1009 deletion) displays a distinct phenotype where the size of the 
colony is reduced, in contrast to wild type and this observation is explained to be 
as a result of polar effects conferred by the downstream ksgA gene (Tufariello, et 
al., 2004). The reduced colony size phenotype in rpfB is not observed in a 
H37Rv background from a distinct study, due to the different nature of the 
deletion, instead fragile, dry colonies on solid media are seen (Downing, et al., 
2004). Interestingly all other mutants, except rpfA, exhibit alterations in colony 
morphology which may be indicative of the function that the gene products serve 
in cell wall biology (Downing, et al., 2004). 
 
Growth of the mutants in vivo (murine aerosol infection model) shows similar 
observations to those seen in vitro. The growth kinetics of the individual mutants 
in the organs of mice is comparable to that of wild type, moreover the 
histopathology of the organs indicate that both mutant and wild type cells behave 
similarly. Thus, growth and persistence of cells is unaffected by single rpf gene 
disruptions (Tufariello, et al., 2004, Downing, et al., 2005, Tufariello, et al., 2006). 
However, other in vivo data report an extended duration of survival of mice 
challenged with the Rv1009 (rpfB) mutant strain in chronic infection, 
furthermore the bacterial loads are conspicuously lower in hepatic and pulmonary 
systems compared to wild type and other single mutant strains (Tufariello, et al., 
2006). The observation indicates the role of RpfB in virulence.  
        
The absence of significant growth/virulence phenotypes led to the hypothesis 
that the individual rpf deletions probably have complete or partially redundant 
functions (Tufariello, et al., 2004). This notion was further supported by gene 
expression analyses which revealed differential and coincidental expression 
patterns of all rpf genes in wild type, in vitro, and possible compensatory 
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increases in gene expression in mutant strains (Downing, et al., 2004, Tufariello, 
et al., 2004). In wild type M. tuberculosis, the highest and lowest expression 
levels are seen for rpfC and rpfE respectively (Downing, et al., 2004, Tufariello, 
et al., 2004) and it has also been shown that rpfB is relatively up-regulated in a 
persistence rabbit model (Kesavan, et al., 2009). Expression of all the rpf genes 
in a clinical strain background is also evident in vivo during acute infection in 
mice, although expression of rpfC was not detected in another independent study 
(Tufariello, et al., 2004, Tufariello, et al., 2006). Another study revealed that M. 
tuberculosis rpf expression has relevance to human infection, although the 
expression of specific rpf genes is not established (Davies, et al., 2008). It is 
likely that each Rpf has a distinct role during different stages of infection 
(Tufariello, et al., 2004). With regards to expression levels in mutant strains, in 
the background of the rpfC mutant, a sizeable amount of genes are observed to 
be differentially expressed in contrast to other rpf mutants. Sress response 
genes, including heat shock, and NADH dehydrogenase genes are up- and 
down-regulated respectively in the rpfC mutant and this is proposed to be due 
to alterations in cell wall metabolism (Downing, et al., 2004).      
       
In light of the fact that all of the rpf genes can be individually depleted from the M. 
tuberculosis genome without impairment or abrogation of growth in vitro and in 
vivo due, possibly, to functional redundancy (Downing, et al., 2004, Tufariello, et 
al., 2004); multiple rpf genes have been serially deleted in M. tuberculosis 
(Downing, et al., 2005, Biketov, et al., 2007, Kana, et al., 2008, Russell-Goldman, 
et al., 2008) in efforts to decipher the biological roles of the gene products.  
 
Of all the double mutant combinations, the rpfA rpfB mutant displays severe 
phenotypes (Russell-Goldman, et al., 2008). Colony morphology is modified with 
reduced serpentine cording at the surface of the colony with the periphery being 
less dense than the central area thus creating a halo appearance (Russell-
Goldman, et al., 2008). All double mutant strains that lack rpfB gene, rpfA rpfB 
and rpfB rpfD, display a retarded reactivation phenotype in a mouse model 
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following immune suppression in chronic infection as initially observed in the 
single mutant rpfB (Tufariello, et al., 2006, Biketov, et al., 2007, Russell-
Goldman, et al., 2008). The defect is even more pronounced in the rpfA rpfB 
mutant; furthermore the strain lacks a persistence phenotype as measured by the 
lower bacterial loads in the organs of mice during chronic infection in contrast to 
those observed for wild type (Russell-Goldman, et al., 2008).  
 
Two triple mutants constructed in the rpfA rpfC genetic background, with 
additional deletion of rpfB and rpfD genes have been assessed for growth and 
survival in stationary phase in vitro (Downing, et al., 2005). The mutants, rpfA 
rpfC rpfB and rpfA rpfC rpfD, survive in stationary phase and growth is 
comparable to wild type (Downing, et al., 2005). Moreover; the multiple mutants 
display a defect in spontaneous resuscitation from a non-culturable state in broth 
medium, unlike the wild type and single rpfB mutant (Downing, et al., 2005). 
Furthermore, growth of the triple mutants was attenuated in a mouse model 
where lower lung bacillary loads were observed as compared to wild type. The 
multiple mutants also displayed an inability to persist in the spleens of the mice, 
unlike wild type and single mutant cells thus indicating reduced virulence 
associated with multiple rpf gene deletion (Downing, et al., 2005).  
 
Deletion of four rpf-like genes in different combinations does not alter the in vitro 
growth phenotype observed in the triple mutants (Kana, et al., 2008). Contrary to 
what is seen in liquid medium, a delayed growth phenotype is observed for a 
quadruple mutant that retains rpfD (rpfA rpfC rpfB rpfE) on solid media. Two 
other quadruple mutants; one that retains rpfE (rpfA rpfC rpfB rpfD), and 
another containing rpfB (rpfA rpfC rpfD rpfE) lack the abovementioned 
colony formation phenotype on solid media. Returning a functional copy of rpfE in 
rpfA rpfC rpfB rpfE reverses the phenotype to normal, wild type-like colony 
formation (Kana, et al., 2008). Moreover, quadruple mutants lacking these genes, 
rpfE and rpfB, are highly sensitive to sodium dodecyl sulfate (SDS), a detergent 
(Kana, et al., 2008).  
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An inverse relationship between gradual depletion of rpf-like genes and gene 
expression is observed with multiple mutants. There seems to be a decline in the 
expression of the remaining rpf-like genes in triple and quadruple mutants due to 
progressive deletion of these genes (Kana, et al., 2008). Growth of the rpfA 
rpfC rpfB rpfE mutant was attenuated in the lungs in a mouse model and 
reduced growth was observed for the rpfA rpfC rpfB rpfD quadruple mutant, 
to levels significantly lower to those of wild type (H37Rv) (Kana, et al., 2008). 
Dissemination of the rpfA rpfC rpfB rpfD and rpfA rpfC rpfB rpfE 
mutants to other organs, the spleen, was impaired as evidenced by low bacterial 
loads for the former and undetectable levels for the latter. Moreover, 90% of mice 
infected with wild type cells succumbed to the disease while all mice survived 
infection with the quadruple mutants (Kana, et al., 2008).     
 
The observation that all five rpf-like genes can be deleted from the genome of M. 
tuberculosis indicates that none of these genes are essential for viability (Kana, 
et al., 2008). The in vitro phenotypes of the quintuple mutant (rpfA rpfC rpfB 
rpfE rpfD) were comparable to those of its quadruple mutant (rpfA rpfC 
rpfB rpfE) progenitor. Similarly, complementation with rpfE and rpfB and not 
rpfC and rpfD genes in the rpfA rpfC rpfB rpfE rpfD mutant restored the 
plating defect as observed in the quadruple mutant (Kana, et al., 2008). 
Surprisingly deletion of all rpf genes from M. tuberculosis does not result in 
increased susceptibility to most drugs tested; however, the mutant does show 
increased susceptibility to erythromycin and vancomycin (Kana, et al., 2010).  
A certain level of functional organization exists within the Rpfs where RpfB and 
RpfE seem to play the most important functions (Kana, et al., 2008) 
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1.5 Aims of this study 
 
To further study the biological function of Rpf-like proteins by assessing the 
effects of rpf gene deletion in M. smegmatis. M. smegmatis is genetically closely 
related to M. tuberculosis but is non-pathogenic and has a faster dividing time, 
making it a more tractable organism to study Rpf function in mycobacteria. 
However, unlike M. tuberculosis, M. smegmatis encodes four (as opposed to 
five) rpf-like genes, thus making it a simpler system to assess rpf-like gene 
function in bacterial growth, cell wall remodeling and dormancy. The specific 
aims are outlined below.  
 
1. Bioinformatics analysis of Rpfs in M. smegmatis. 
2. Construction of mutants defective for one or more rpf genes. 
3. Evaluate the effect of rpf gene depletion on growth and survival of the 
organism. 
4. Evaluate the effect of rpf gene loss on susceptibility to different cell wall 
stresses. 
5. Assess the role of Rpfs on cell morphology. 
.  
 
 
 
 
 
 
.  
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2.  Materials and Methods 
 
2.1 Bacterial strains and growth conditions 
 
All strains and plasmids used in this study are listed below in Table 1. 
Escherichia coli strains were stored at -70˚C in 66% glycerol and M. smegmatis 
strains were stored at -80˚C in growth medium (details below). 
 
E. coli DH5 cells, and their transformants, were grown at 37˚C in Luria Bertani 
(LB) broth or agar (LA) containing appropriate selection antibiotics (ampicillin 100 
µg/ml, hygromycin 200 µg/ml or kanamycin 50 µg/ml) for all plasmid DNA 
manipulation purposes. M. smegmatis mc2155 was grown at 37˚C in Middlebrook 
7H10 agar or 7H9 broth supplemented with 0.2% glucose, 0.85% salt and 0.05% 
Tween or 0.02% Tyloxapol. Hygromycin (Hyg) 50 µg/ml and/or kanamycin (Km) 
25 µg/ml were added where appropriate. M. smegmatis rpf deletion mutant 
strains were grown as wild type, with the exception of the complemented 
derivative which required addition of Hyg to a final concentration of 50 µg/ml for 
maintenance of the complementing vector (see Appendix C, Figure A2). 
 
2.2 General Laboratory Techniques 
 
2.2.1 DNA isolation 
 
2.2.1.1 Isolation of genomic DNA from M. smegmatis  
 
In all cases, freezer stocks for the relevant strains were thawed and 100 µl of 
liquid culture was removed and placed on 7H10 solid media. This was incubated 
for 3 days. The cells were scraped off the plate with an inoculating loop and re-
suspended in 500 µl TE buffer. The cell suspension was heat killed at 70˚C for 35 
min followed by brief cooling on ice.  
32 
 
Table 1: Strains and plasmids used in this study 
 
Name  Description Source 
Strains 
M. smegmatis mc2155 M. smegmatis ATCC 607 high frequency transformation 
mutant 
(Snapper, et al., 1990) 
E. coli DH5 supE44 lacU169 hsdR17 recA1 endA1 gyrA96 thi-1 relA1 Promega, Madison, WI 
rpfA Derivative of M. smegmatis mc2155, carrying an in-frame 
deletion in rpfA   
This work 
rpfB Derivative of M. smegmatis mc2155 carrying an in-frame 
deletion in rpfB 
This work 
rpfA rpfB Derivative of M. smegmatis rpfA carrying an in-frame 
deletion in rpfB 
This work 
rpfA rpfB rpfC Derivative of M. smegmatis rpfA rpfB carrying an in-frame 
deletion in rpfC   
This work 
rpfA rpfB::pMVRPFAB Derivative of M. smegmatis rpfA rpfB carrying pMRPFAB 
integrated at the attB phage attachment site 
This work 
Plasmids   
pGEM3Z(+)f E. coli cloning vector; AmpR Promega 
pGEM-T Easy E. coli PCR TA cloning vector; AmpR Promega 
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pBluescript  E. coli cloning vector; AmpR Promega 
P2NIL E. coli cloning vector; KmR (Parish & Stoker, 2000) 
pGOAL19 Plasmid consisting of a PacI cassette carrying hygR, lacZ and 
SacB genes; AmpR 
(Parish & Stoker, 2000) 
pOLYG E. coli-Mycobacterium shuttle vector; HygR (Ã“ Gaora, et al., 1997) 
pGUrpfA pGEM3Z(+)f cloning vector carrying a homologous region 
upstream of rpfA which includes 46 bp of the 5’ end of rpfA 
and a further 853 bp of upstream sequence encoding for 
moaA and MSMEG_5699 genes; AmpR  
This work 
pGDrpfA pGEM3Z(+)f cloning vector carrying a homologous region 
downstream of rpfA which includes 56 bp of the 3’ end of 
rpfA and a further 832 bp of downstream sequence encoding 
for moaE and MSMEG_5702 genes; AmpR 
This work 
pBUrpfB pBluescript cloning vector carrying a homologous region 
upstream of rpfB which includes 49 bp of the 5’ end of rpfB 
and a further 772 bp of upstream sequence encoding for 
ksgA gene; AmpR 
This work 
pBDrpfB pBluescript cloning vector carrying a homologous region 
downstream of rpfB which includes 4 bp of the 3’ end of rpfB 
and a further 693 bp of downstream sequence encoding for 
This work 
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MSMEG_5440 gene; AmpR 
pGRPFA Derivative of pGEM3Z(+)f carrying the in-frame rpfA deletion 
allele created by the ligation of the abovementioned 
upstream and downstream regions; AmpR  
This work 
pGRPFB Derivative of pGEM3Z(+)f carrying the in-frame rpfB deletion 
allele created by the ligation of the upstream and 
downstream regions; AmpR 
This work 
pNRPFA Derivative of p2NIL carrying the in-frame rpfA deletion allele 
from pGRPFA, intermediate knockout construct; KmR  
This work 
pNRPFB Derivative of p2NIL carrying the in-frame rpfB deletion allele 
from pGRPFB, intermediate knockout construct; KmR 
This work 
pSVRPFA Derivative of pNRPFA carrying the lacZ, sacB and hygR 
marker gene cassette from pGOAL19, final knockout 
construct; HygR, KmR 
This work  
pSVRPFB Derivative of pNRPFB carrying the lacZ, sacB and hygR 
marker gene cassette from pGOAL19, final knockout 
construct; HygR, KmR 
This work 
pSVRPFCE Knockout construct for deletion of rpfC and rpfE, carrying the 
lacZ and sacB marker gene cassette from pGOAL17, KmR 
E. Machowski 
pMRPFAB Derivative of pMV306H carrying rpfA and rpfB; HygR E. Machowski 
AmpR, HygR, KmR:  ampicillin-, hygromycin-, kanamycin resistance. 
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The heat-killed cells were treated with 50 µl lysozyme (10 mg/ml) and incubated 
at 37˚C for an hr; thereafter 70 µl of 10% SDS and 6 µl proteinase K (10 mg/ml) 
were added. This was further incubated at 65˚C for 1.5 - 2 hrs. Following 
incubation; 100 µl of 5 M NaCl was added, mixed and 80 µl CTAB/NaCl solution 
(10% CTAB in 0.7 M NaCl) was added to the mixture followed by gentle, 
thorough mixing through careful inversion of the tubes. The mixture was 
incubated at 65˚C for 10 min which was followed by the addition of 750 µl of 
chloroform: isoamyl alcohol (24:1 v/v). The aqueous and organic phases were 
mixed by inversion and separated by centrifugation at 13000 rpm for 5 min. The 
aqueous layer was collected into sterile Eppendorf tubes and DNA was 
precipitated by addition of 450 µl isopropanol and incubation on ice for 30 min. 
DNA was harvested by centrifugation for 20 min at 13000 rpm. The pellet was 
washed with ice cold 70% ethanol and dried under a vacuum. The pellet was re-
constituted in 50 -100 µl sterile distilled water, depending on the size of the pellet.  
 
2.2.1.2 E. coli plasmid DNA extraction (Mini-prep)  
 
Overnight (1.5 ml) cultures were briefly centrifuged (13000 rpm) and the cell 
pellets were re-suspended in 100 µl cold solution I (0.05 M glucose, 0.01 M 
EDTA, 0.025 M Tris-HCl, distilled H20). A volume of 200 µl room-temperature 
solution II (0.2 M NaOH, 1% SDS, distilled H20) was added to the cell 
suspension, followed by gentle mixing and incubation on ice for 5 min. A further 
addition of 150 µl chilled solution III (3 M potassium acetate, 11.5% glacial acetic 
acid, distilled H20) was made to the suspension followed by mixing and 
incubation on ice for 10 min. The suspension was then centrifuged at 13000 rpm 
for 10 min and supernatants were collected into sterile Eppendorf tubes 
containing 1 µg/ml RNAseA. RNA was digested at 42˚C for 30-60 min. DNA was 
precipitated by the addition of an equal volume (~ 450 l) of isopropanol and the 
pellets were washed with 70% ethanol, dried under vacuum at 45˚C for 20 min 
and re-suspended in 10-20 µl sdH20. 
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2.2.1.3 E. coli plasmid DNA purification (Maxi-prep) 
 
100 ml cultures grown overnight were harvested by centrifugation (4500 rpm) for 
10 min at 4˚C. Purified DNA was extracted with the use of the NucleoBond kit 
(Macherey-Nagel) in accordance with manufacturer’s instructions. 
 
2.2.2 DNA manipulation 
 
2.2.2.1 Restriction endonuclease digestion 
 
All restriction endonucleases, and their buffers, used were from Roche 
Diagnostics (Mannheim, Germany) or New England Biolabs. The total digestion 
reaction volume varied, depending on the concentration or amount of DNA used 
and application. Concentration, as quantified by UV spectroscopy (absorbance at 
260 nm on the Nanodrop spectrophotomer – NanoDrop Technologies see 
section 2.2.6), of plasmid DNA used was within the range of 1-2 µg in a total 
reaction volume of up to 30 µl. A one-tenth volume of buffer and 1 µl restriction 
enzyme were added to the reaction with sterile distilled water making up the rest 
of the total volume. For restriction digestions with two enzymes, both enzymes 
were added in a single reaction with a compatible restriction buffer. Reactions 
were incubated at room temperature, 30˚C or 37˚C for 1 hr as per manufacturer’s 
instructions for individual enzymes.  
 
2.2.2.2 Dephosphorylation of plasmid DNA 
 
Antarctic phosphatase (New England BioLabs) was employed for removal of 5’ 
phosphate groups from DNA to prevent re-circularization of cloning vectors. A 
one-tenth volume of 10x Antarctic phosphatase buffer was added to heat-
inactivated restriction digestion reaction, mixed and briefly centrifuged. Antarctic 
phosphatase enzyme (1 µl) was added, mixed thoroughly and incubated at 37˚C 
37 
 
for 1 hr. Subsequent to incubation; the DNA was visualized on agarose gels 
(section 2.2.4) and purified by gel extraction (section 2.2.5) to ensure that linear 
vector, free of any phosphatase, was used for subsequent cloning steps.  
 
2.2.2.3 Ligations 
 
All ligations were carried out with the use of a Fast-Link DNA Ligation Kit 
(Epicentre Biotechnologies; Madison, Wisconsin), according to instructions 
supplied in the manufacturers’ manual. Plasmid vector and insert were prepared 
by digestion (section 2.2.2.1), gel purification (2.2.5) and quantification (2.2.6). A 
standard of 50 g of vector was used for all ligation reactions. The molar amount 
of insert DNA to be added to 50 g of vector DNA to obtain equivalent numbers 
of vector and insert molecules in the ligation reaction was calculated as follows:   
m = 50ng X bpI           Volinsert =     mass 
           bpV                              concentration        
 
m – amount of insert DNA for 50 g of vector, I- insert size, V- vector size, bp- 
size of insert or vector in base pairs. 
 
The calculated insert volume was added to the ligation reaction for every 50 ng of 
vector in different Vector: Insert ratios, with an increment of insert added for each 
ratio. The standard ratios used for all ligations were 1:1 Vector: Insert, 1:2 Vector: 
Insert and 2:1 Vector: Insert. The reaction was incubated at 25˚C for 1 hr and 
heat inactivated at 65˚C for 10 min. 
 
2.2.3 DNA precipitation 
 
For ethanol salt precipitation of DNA, one-tenth volume of 3 M Sodium acetate 
(pH 5.2) was added to DNA and briefly inverted. This was followed by the 
addition of 2.5 volume ice-cold 100% ethanol and mixing by inversion. The 
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mixture was incubated at -20˚C for 20 min and the DNA pellet was harvested by 
centrifugation at 13000 rpm for 20 min. The supernatant was decanted and the 
DNA pellet was washed with ice-cold 70% ethanol. DNA was dried under 
vacuum and re-constituted in sterile distilled water. 
 
2.2.4 Gel electrophoresis   
 
All DNA samples were separated and viewed in 1% agarose gels and these were 
visualized with the use of a gel fluorescence imaging system; G:BOX and 
GeneSnap image acquisition software (Syngene). The gels were prepared by 
dissolving agarose powder (Invitrogen, Life Technologies), by heating to boiling 
point, in 1X TAE buffer (40 mM Tris-acetate, 1 mM EDTA) to a final concentration 
of 1%. For every 30 ml of dissolved agarose suspension, 2 l of ethidium 
bromide (10 mg/ml) was added to the cooled agarose solution which was then 
poured into gel trays, consisting of gel combs, balanced on gel casters. Once set; 
the gels were placed in electrophoresis tanks (Biorad Laboratories) submerged in 
1X TAE buffer and the DNA samples, combined with gel loading dye (0.04 g 
bromophenol blue, 30% glycerol, 70% sdH20), were loaded in wells. The gels 
were generally run at 0.4 A, 90 V but in other instances the voltage was lower, 
depending on application. Molecular weight markers (Roche Diagnostics; 
Mannheim, Germany) were run simultaneously with DNA samples to aid in 
determining the size of DNA fragments.  
 
2.2.5 Gel extraction and purification 
 
Following gel electrophoresis, the gel was placed on a UV transilluminator 
(Fotodyne Incorporated) and DNA was visualized with UV light. DNA fragments 
of interest were excised out of the gel using a sterile scalpel. The mass of the gel 
slice was weighed and the DNA was extracted from the gel with the use of a 
PCR clean-up Gel extraction kit (NucleoSpin Extract II, Macherey-Nagel), in 
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accordance to instructions supplied by manufacturers’ manual. The DNA was 
quantified as described below. 
 
2.2.6 DNA quantification   
 
Following DNA and/or gel extraction, the DNA was quantified by NanoDrop ND-
1000 Spectrophotometer (NanoDrop Technologies) used in conjunction with 
software (Coleman Technologies) provided by the manufacturer. In other 
instances, DNA was quantified by estimation of DNA amounts on gels. For this, 
gel electrophoresis (section 2.2.4) was conducted for the DNA of interest and a 
comparison was made between the intensity of bands to that of similar size 
bands in the molecular weight marker, the concentration of which are provided by 
the manufacturer. 
 
2.2.7 Preparation of E. coli DH5 competent cells using rubidium chloride   
 
E. coli DH5 cells were grown from a pre-culture in 100 ml Psi broth at 37˚C, with 
aeration, to OD600nm ~ 0.48 - 0.52. The culture was placed on ice for 15 min and 
the bacterial cells were harvested by centrifugation (3500 rpm, Allegra X-22R, 
Beckman Coulter) for 5 min. The supernatant was discarded, the cell pellet was 
re-suspended in 0.4 volume TfbI (15% v/v glycerol, 30 mM potassium acetate, 
100 mM rubidium chloride, 10 mM calcium chloride, 50 mM manganese chloride) 
and the cell suspension was incubated on ice for 15 min. Centrifugation was 
repeated and the pellet was re-suspended in 0.04 volume TfbII (10 mM MOPS, 
75 mM calcium chloride) with subsequent incubation on ice for another 15 min. 
The cells were used immediately or frozen in ethanol at -70˚C for later use. In all 
cases, the transformation efficiency was determined to be between 1 X108 -1 
X109 CFU/µg DNA. 
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2.2.7.1 Transformation of E. coli competent cells 
 
The competent E. coli DH5 cells were thawed on ice and 4 µl of ligation reaction 
was added in 100 µl aliquots of cells. This was incubated on ice for 25 min, 
followed by heat shocking for 90 sec at 42˚C. The DNA-cell suspension was 
returned to ice for 2 min and thereafter, rescued with 800 µl LB. A subsequent 
incubation period was carried out for 45-60 min at 37˚C. Following incubation, the 
cells were centrifuged (5000 rpm) for 10 min and re-suspended in 100 µl fresh 
LB. The cell suspension was spread on appropriate antibiotic-containing solid 
media and incubated overnight at 37˚C.  
 
2.2.8 PCR screening of E. coli transformants 
 
E. coli clones selected on appropriate antibiotic-containing solid media were 
picked and re-suspended in 20 µl broth. The cell suspension (5 µl) was used as 
template DNA in a Taq PCR (Faststart Taq DNA Polymerase, dNTPack kit, 
Roche Diagnostics) with the appropriate primers and cycling conditions. The 
PCR was carried out as stipulated in the manufacturers’ manual. The remaining 
cell suspension was used to start cultures for any positive clones.  
 
2.2.9 Serial dilutions 
 
A series of ten-fold dilutions were performed by adding 100 µl undiluted culture, 
100, to an Eppendorf tube containing 900 µl broth followed by mixing with gentle 
vortexing. Thereafter, 100 µl of the 10X diluted culture, 101, was then added (100 
µl) to the next tube containing 900 µl broth and mixed as before. This procedure 
was repeated to obtain the entire dilution series, usually up to 107 for most 
applications.  
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2.2.10 DNA sequencing 
 
The constructs consisting of upstream and downstream rpf PCR fragments 
cloned separately to high-copy plasmid vectors (pBluescript and pGEM) were 
sent for sequencing at Inqaba Biotec (Pretoria, RSA). The purified plasmids were 
sequenced with the use of M13 universal primers and the sequencing data was 
analyzed with the SeqMan module from DNASTAR program. 
 
2.3 Bioinformatics analysis of rpf genes in M. smegmatis 
 
The bioinformatics program ACT (Artemis Comparison Tool) was used to 
compare the M. tuberculosis rpf genes with their M. smegmatis homologues 
within their relative genomic context. A linear, genomic map of the region 
upstream and downstream of each rpf-like gene in M. smegmatis was created 
using the abovementioned tool. 
 
M. tuberculosis and M. smegmatis rpf protein sequences were taken from 
Artemis or NCBI, http://www.ncbi.nlm.nih.gov/genomes//proks.cgi, and the 
overall homology between the rpf gene products in both organisms was analyzed 
using BLAST http://blast.ncbi.nlm.nih.gov/ or http://blast.jcvi.org/cmr-blast/. The 
prediction of signal peptides within Rpf amino acid sequences was carried out by 
submission of Rpf protein sequences to SignalP 4.0 server, 
http://www.cbs.dtu.dk/services/signalp.    
 
2.4 Construction of rpf-knockout mutants 
      
The method of choice for gene deletion was allelic exchange using homologous 
recombination and a suicide plasmid (Parish & Stoker, 2000). For this method 
homologous regions located upstream and downstream of the gene of interest 
are required. These regions are then fused by cloning into the suicide vector to 
create a deletion allele. For this, primers were designed to amplify the regions 
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upstream and downstream of rpfA and rpfB. These primers were designed with 
engineered restriction sites to facilitate cloning into the suicide vector to produce 
the deletion allele, Table 2. The primers were designed with the use of an online 
program, Primer 3 http://frodo.wi.mit.edu/primer3/. Asp718 and BglII recognition 
sequences were included in forward and reverse primers respectively for all 
upstream region amplicons. Similarly, the forward and reverse primers for all 
downstream regions contained BglII and HindIII recognition sequences 
respectively. As mentioned above, these restriction enzyme recognition 
sequences were engineered for cloning purposes and were included in the 
generation of knockout constructs for MSMEG_5700 (rpfA) and MSMEG_5439 
(rpfB).  
 
2.4.1 Polymerase Chain Reaction (PCR) 
 
In order to generate upstream and downstream rpf DNA fragments, PCR was 
carried out with rpfA/rpfB forward and reverse primers shown in Table 2. The 
cycling conditions were performed as follows: the first step, denaturation, 
proceeded at 95˚C for 5 min, followed by a further 35 cycles of denaturation at 
95˚C for 30 sec, an annealing step at 60˚C for 30 sec and elongation at 72˚C for 
150 sec. A final step of elongation at 72˚C for 10 min was included and the 
reaction concluded with a cooling and holding temperature step set at 16˚C.  
  
The PCR was initially carried out using Faststart Taq DNA Polymerase, dNTPack 
kit (Roche Diagnostics; Mannheim, Germany) according to manufacturer’s 
instructions for optimization PCR cycling conditions. Following this optimization 
step, Phusion High-Fidelity DNA Polymerase (Finnzymes) and Expand High-
Fidelity Polymerase (Roche Diagnostics) PCR was performed according to 
manufacturer’s instructions. In the case of Phusion PCR, the annealing 
temperature was changed to 62˚C, to reduce non-specific amplification, while the 
remaining reaction conditions remained unaltered. Genomic DNA from M. 
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smegmatis mc2155 (section 2.2.1.1) was used as a template in these PCR 
reactions. 
 
2.4.2 Construction of knockout vectors for rpfA and rpfB   
 
2.4.2.1 Cloning of upstream and downstream homologous regions  
 
The Phusion PCR products corresponding to the rpfA and rpfB upstream and 
downstream homologous regions were separated and viewed on gels by agarose 
gel electrophoresis (section 2.2.4). These fragments were then purified by gel 
extraction as previously described (section 2.2.5). A high-copy plasmid vector, 
pBluescript was prepared by plasmid extraction (section 2.2.1.3) and linearized 
by digestion (section 2.2.2.1) with SmaI. The linearized plasmid vector was 
viewed on agarose gels subsequent to gel electrophoresis and purified by gel 
extraction. The purified linear plasmid and PCR amplicons were quantified 
(section 2.2.6) and the rpfB upstream and downstream regions were cloned 
separately into pBluescript to yield pBUrpfB and pBDrpfB respectively. 
Similarly, the rpfA upstream and downstream regions were cloned separately by 
ligation (section 2.2.2.3) into pGEM3Z(+)f with the use of a pGEM-T Easy Vector 
system kit (Promega, Madison) according to instructions supplied by the 
manufacturer. Ligation reactions were transformed (section 2.2.7.1)  into E. coli 
DH5 cells followed by selection of white, AmpR clones on LA plates containing 
100 µg/ml ampicillin (Amp) and 2% 5-bromo-4-chloro-3-indolyl--D-
galactopyranoside (X-gal). These clones were picked and screened by PCR to 
confirm the correct cloned insert.  
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Table 2: Oligonucleotide sequences used in the construction of rpf knockout strains in M. smegmatis. Bold bases 
represent engineered restriction enzyme recognition sequences for cloning purposes. 
 
Gene Mutant 
allele 
Internal 
deletion size 
Knockout 
vector used 
Oligonucleotide pairs used in the construction of vectors 
5’-3’ sequence Region amplified 
rpfA rpfA 1359 bp pSVRPFA GGGGGGTACCGATCTGCGGCACCTGCTG 
GGGGAGATCTTGGCAGATGACGAAGAAG  
46 bp of the 5’ end of 
rpfA and 853 bp of 
homologous upstream 
sequence. 
GGGGAGATCTGCCCCGGTGGGCGCACCGG  
GGGGAAGCTTCCCGACGGCGACGCCGTGG  
56 bp of 3’ end of rpfA 
and 832 bp of 
homologous 
downstream sequence. 
rpfB rpfB 1075 bp pSVRPFB GGGGGGTACCTGGACGCGGCACATTGGG  
GGGGAGATCTCGAAGCAACGGCGAGCGGG  
49 bp of 5’ end of rpfB 
and 772 bp of 
homologous upstream 
sequence.  
GGGGAGATCTGACTATTCGACTGCTCGGG 
GGGGAAGCTTGCGGCGCTGCGCGAAGCC  
4 bp of the 3’ end of rpfB 
and 693 bp of 
downstream sequence. 
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Small scale plasmid DNA extraction (section 2.2.1.2) was carried out from 
positive clones and the resulting DNA was digested with enzymes to release 
cloned upstream and downstream inserts. Asp718 and BglII enzymes were used 
to release the upstream fragment, while BglII and HindIII enzymes were used to 
release the downstream fragment; the digested constructs were viewed on 
agarose gels following gel electrophoresis. The correct clones were picked and 
grown in LB containing 100 µg/ml Amp and a large scale plasmid DNA extraction 
was performed (section 2.2.1.3). The purified constructs were sent for 
sequencing (section 2.2.10) to confirm that no mutations were inadvertently 
introduced during PCR amplificaiton. 
 
2.4.2.2 Three-way cloning 
 
The upstream and downstream rpfA and rpfB fragments were digested with 
appropriate enzymes from the high-copy plasmid vectors and simultaneously 
ligated to purified p2NIL (Parish & Stoker, 2000) plasmid vector by three-way 
cloning (illustrated in section 3.2.1.3, Figure 15). The p2NIL vector was prepared 
by DNA extraction from E. coli DH5 cells and digested with Asp718 and HindIII. 
White, KmR clones were selected on 50 µg/ml kanamycin-containing LA, 
following E. coli transformation. The clones were screened by PCR (section 
2.2.8) and restriction analysis of extracted plasmid DNA, from putative correct 
clones was carried out. Three-way cloning was also carried out with 
pGEM3ZF(+) as the vector backbone using the same restriction enzymes and 
cloning strategy. 
 
2.4.2.3 Cloning of PacI cassette 
 
The p2NIL intermediate knockout constructs (pNRPFA and pNRPFB) and 
pGOAL19 vector were digested with PacI restriction enzyme and the relevant 
fragments were purified from gels for cloning. The PacI cassette (containing the 
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selectable – lacZ – and counter selectable – sacB – markers) from pGOAL19 
was cloned into linearized, dephosphorylated (section 2.2.2.2) pNRPFA and 
pNRPFB constructs. Ligation reactions were transformed into E. coli followed 
by selection of blue, KmR clones on LA containing 50 µg/ml Km and X-gal at 
30˚C. This step of cloning completed the construction of the final suicide delivery 
vectors. The clones were grown for 3 days in broth containing Km at 30˚C and 
tested for sucrose sensitivity on 5% sucrose. The cultures were serially diluted 
(section 2.2.9) from 101 to 107, plated on LA plates containing 50 µg/ml Km, with 
and without 5% sucrose and incubated at 30˚C for 3 days. Putative positive 
clones were further analyzed by extensive restriction analysis.    
 
2.4.3 M. smegmatis mc2155 competent cells preparation 
 
For transformation of M. smegmatis (mc2155 or mutant strains), a pre-culture 
was grown overnight from freezer stocks to stationary phase in 7H9 broth at 
37˚C, with 100 rpm rotary shaking. This culture was then diluted 1:100 in fresh 
media and grown overnight at 37˚C to O.D. 0.8. The cells were harvested by 
centrifugation (4500 rpm) for 10 min and the cell pellets were re-suspended in 30 
ml 10% ice-cold glycerol, cells were kept on ice at all times. Centrifugation was 
carried out again and the cells were repeatedly washed with 10% glycerol four 
times. The cells were kept on ice, in glycerol suspension, until they were 
electroporated with the relevant constructs.  
 
2.4.3.1 Electroporations 
 
Electro-competent cells were added to Gene Pulser 2 mm cuvettes (Bio-Rad 
Laboratories) in 400 µl aliquots followed by addition of plasmid DNA (knockout 
constructs/suicide vectors, complementing vectors and pOLYG) at varying 
concentrations (1-5 µg) with gentle mixing to prevent the formation of air bubbles. 
The Gene Pulser Xcell (Bio-Rad Laboratories) was used for electroporations with 
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the following settings: the voltage was set at 2500 V, capacitance at 25 µF, 
resistance at 1000  and cuvette size at 2 mm. Cuvettes were placed into the 
shock pod and the cells were electroporated for delivery of plasmid DNA into 
cells. The cells were rescued immediately with 800 µl 7H9 broth with brief 
incubation on ice followed by incubation at 37˚C for 3 hrs or overnight. Blue 
HygR, KmR M. smegmatis clones were selected on 7H10 solid media containing 
X-gal, 50 µg/ml Hyg and 20 µg/ml Km or 50 µg/ml Hyg only for serially diluted 
pOLYG control. A ‘No DNA’ control was included in the electroporations.  
Blue colonies selected from these plates were grown overnight in 5 ml 7H9 broth 
containing 20 µg/ml Km at 37˚C; thereafter 200 µl of the above culture was used 
as inoculum in 10 ml of 7H9 broth without antibiotic. Cells from the 10 ml culture 
were harvested by centrifugation (4500 rpm) for 10 min and the pellet was re-
suspended in 400 µl broth. A 100 µl fraction of the cell suspension was spread 
on 7H10 plates containing 2% sucrose and this was done in duplicate while 
another was spread on solid media without sucrose. The remaining 100 µl 
fraction was serially diluted from 101 to 107. A 100 µl volume of each dilution was 
spread on solid media containing X-gal, 2% sucrose and without sucrose. The 
plates were incubated at 37˚C for 3-5 days. White, SucR colonies, possible rpf 
deletion mutants, were picked and screened by PCR as described below.  
 
2.4.4 Screening for M. smegmatis rpf deletion mutants by PCR 
 
White SucR colonies were re-suspended in 50 µl sterile water and 10 µl of the cell 
suspension was used to make cell spots on 7H10 plates for future use. The rest 
of the cell suspension was boiled at 95˚C for 5 min, 40 µl phenol chloroform was 
added and briefly vortexed. The contents were centrifuged (13000 rpm) for 5 min 
and the aqueous layer was removed and placed into a sterile Eppendorf tube. 
The extracted genomic DNA was used as template DNA in the Taq PCR reaction 
using the primers described in Table 3 and following manufacturer’s instructions.  
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All three allelic-specific primers, shown below in Table 3, were used in a reaction 
for screening each rpf mutant (illustrated in section 3.2.2, Figure 28 and 29). The 
cycling conditions were performed as follows: the denaturation step proceeded at 
95˚C for 5 min and was followed by 30 cycles of further denaturation at 95˚C for 
30 sec, an annealing step at 60˚C for 30 sec and extension at 72˚C for 40 sec. 
Final extension proceeded at 72˚C for 7 min and the reaction concluded with a 
cooling and holding temperature step set at 16˚C. The PCR products were 
viewed on 1% agarose. 
 
2.4.5 Southern blot analysis 
 
A concentration range of between 1-2 µg extracted M. smegmatis, wild type and 
rpf mutant genomic DNA was digested with appropriate enzymes and incubated 
overnight at the appropriate temperature. The fragmented genomic DNA was 
separated by gel electrophoresis at 80 V in 1% agarose gels (section 2.2.4). The 
gels were submerged in 0.2 M HCl for 15 min with continuous shaking for 
depurination of DNA. The acid solution was discarded and the gels were rinsed 
twice in distilled H20 and placed in a solution of 0.5 M NaOH /1.5 M NaCl. The 
gels were left submerged in the solution for 30 min with continuous shaking to 
allow for DNA denaturation. The solution was discarded and gels were 
equilibrated with 1X TBE buffer (89 mM Tris-Borate, 2 mM EDTA, pH 8.3) for 5 
min. 
 
The DNA was transferred from gels to membranes by sandwiching the gels and 
membrane (Hybond-N, Amersham), in 1X TBE buffer, between layers of thick 
and thin foam sponges, and blotting paper. The “sandwiches” were encased in 
gel cassettes (Amersham) and transferred to a tank transfer unit (Hoefer TE 22, 
Amersham) containing the same buffer. DNA was transferred at 0.6 A, 0.5 V for 2 
hrs at 4˚C.  
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Table 3: Allelic-specific oligonucleotide sequences used in this study for rpf deletion mutant DNA screening. F and R 
represent forward and reverse primers respectively.  
 
Oligonucleotide name Sequence 5’ – 3’ Region targeted 
rpfA- F GAGGACCTCGACGCTTATGA 4 bp of the 5’ end of rpfA and 296 bp of 
internal rpfA sequence or 1524 bp of 
internal rpfA sequence including 47 bp of 
downstream homologous sequence 
rpfA- R1 TCCTTGGTGGCCATGTACGC 
rpfA- R2 ACCGACGAGTGGGTCAACTC 
  
rpfB- F AGGACCACACGACAGCCGTG 3 bp of the 5’ end of rpfB and 296 bp of 
internal rpfB sequence or 1240 bp of 
internal rpfB sequence including 96 bp of 
downstream homologous sequence 
rpfB- R1 CGGCTGCGGCGCAACACGAT 
rpfB- R2 CATCGTGGACGAAGTTCTGT 
  
rpfC- F GAACGTTTGTACGGCAGTGA 4 bp of the 5’ end of rpfC and 297 bp of 
internal rpfC sequence or 560 bp of 
internal rpfC sequence including 82 bp of 
downstream homologous sequence 
rpfC- R1 GCCAGACCCTGGGTGCGCAG 
rpfC- R2 GCGCGACCGTGCTGGTGCCC 
  
rpfE- F TGGCGAAAGGAACGAAGTGA 4 bp of the 5’ end of rpfE and 296 bp of 
internal rpfE sequence or 422 of internal 
rpfE sequence including 82 bp of 
downstream homologous sequence  
rpfE- R1 TGGGTACGCAGCACGTTCTC 
rpfE- R2 GCAGAAGGGCCTGGAGAGGA  
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After electroblotting, the membranes were removed from “sandwiches” with 
forceps, placed on blotting paper and allowed to air-dry. Membranes were then 
placed in a pre-warmed UV crosslinker (UVC 500, Amersham Biosciences) with 
the transferred DNA at the membrane surface and the DNA was crosslinked at 
120 000 µJ/cm2 for 2 min. This was repeated twice. 
 
A DIG High Prime DNA Labeling and Detection Starter Kit (Roche Diagnostics; 
Mannheim, Germany) was used for hybridization, labeling and detection. Probe 
hybridization and washes were performed in the Hybaid (Thermo Scientific) 
system with associated bottles. The hybridization temperature was calculated to 
be between 52-54˚C according to the formula given in the manufacturers’ 
manual. Membranes were pre-hybridized in roller bottles containing DIG Easy 
Hyb Granules solution (Roche Diagnostics; Mannheim, Germany) for 2 hrs in the 
oven by rotation. A DIG-labeled DNA probe was synthesized using a PCR DIG 
Probe Synthesis Kit according to instructions provided in the manufacturers’ 
manual. Constructs listed in Table 1 (pGDrpfA, pBUrpfB, pBDrpfB, 
pSVRPFCE) were used as template DNA in the above PCR reactions and 
Primers listed in Table 2 were also included in the reaction. The probes were 
added to the membranes and hybridized overnight. The membranes were 
washed twice at room temperature in 25 ml solution containing 2X SSC (300 mM 
NaCl, 30 mM Sodium citrate) and 0.1% SDS for 5 min. This was followed by 
another two washes at 68˚C in 25 ml solution containing 0.5X SSC (75 mM NaCl, 
7.5 mM Sodium citrate) and 0.1% SDS. 
 
2.4.5.1 Digoxigenin (DIG)-dUTP labeling and detection 
 
Membranes were transferred to a glass dish and equilibrated with 20 ml 1X wash 
buffer containing 1X Maleic acid buffer (10 mM Maleic acid, 15 mM NaCl, pH 7.5) 
and 0.3% Triton X-100 for 5 min. The buffer was discarded and 120 ml 1X 
blocking buffer consisting 1X Maleic acid buffer and 1X blocking solution (DIG 
High Prime DNA Labeling and Detection Starter Kit, Roche Diagnostics) was 
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added and allowed to shake at room temperature for 30 min. The blocking buffer 
was discarded and another 25 ml fresh blocking buffer and 25 µl Anti-
Digoxigenin- AP Fab fragments (DIG High Prime DNA Labeling and Detection 
Starter Kit, Roche Diagnostics) were added to membranes. This was allowed to 
shake at room temperature for 30 min and discarded. Another two washes in 120 
ml 1X wash buffer were conducted at room temperature for 15 min. The 
membranes were equilibrated with 25 ml detection buffer (50 mM Mg2Cl, 0.1 M 
Tris-HCl, 1 M NaCl, and pH 9). 
 
Membranes were inserted in hybridization bags (Roche Diagnostics; Mannheim, 
Germany), and chloro-5-substituted adamantyl-1, 2-dioxetane phosphate (CSPD) 
substrate was added to membranes for chemiluminescent detection of probe. 
Probe-complementary DNA sequence hybrids were revealed on X-ray film 
following membrane exposure to the film and incubated at room temperature for 
30 min-2 hrs. 
 
2.5 Growth kinetics 
 
Overnight pre-cultures of M. smegmatis wild type, rpfA, rpfB, rpfA rpfB, 
rpfA rpfB rpfC and rpfA rpfB::pMVRPFAB strains were inoculated in 100 
ml 7H9 broth to a starting OD600nm (optical density at 600nm) of 0.01. The 
cultures were placed in a 37˚C shaking incubator (115 rpm; IncoCool, Labotec) 
over a period of 33 hrs. Aliquots were taken every 3 hrs and OD600nm readings 
were determined on a Shimadzu UV1601 spectrophotometer. At these time 
points, colony forming units (CFUs) were enumerated by plating ten-fold serial 
dilutions on solid media. Plates were incubated at 37˚C for 5-7 days. These 
experiments were repeated three times to confirm biological reproducibility. 
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2.6 Drug susceptibility assay  
 
Cultures of the six different strains were grown at 37˚C in a shaking incubator 
from overnight pre-cultures to an OD600nm of 0.4. The cultures were serially 
diluted from 100 to 106; and 10 µl of each dilution was spotted on detergent 
(sodium dodecyl sulfate - SDS) and antibiotic-containing 7H11 solid media. A no 
treatment control was included in the assay. Antibiotics (Sigma-Aldrich) used 
were 2000 µg/ml carbenicillin, 150 µg/ml D-cycloserine, 10 µg/ml erythromycin, 6 
µg/ml vancomycin and SDS (Sigma-Aldrich) was used at concentrations of 
0.001% and 0.005%. CFUs were also determined by plating ten-fold serial 
dilutions on antibiotic containing and antibiotic free media. All plates were 
incubated at 37˚C for 4 days. Three biological replicates were performed to 
ensure reproducibility of results. 
 
2.7 Analysis of changes in colony morphology  
 
M. smegmatis wild type, rpf deletion mutants and complemented strain were 
grown in culture to an OD600nm of 0.5 from an overnight pre-culture. A ten-fold 
dilution series was carried out for all cultures, 104-106 dilutions were plated on 
7H10 solid media for each strain. The plates were incubated at 37˚C for 5 days. 
Colony morphology differences were analyzed on a Vacutec G-Box Gel 
documentation/photography system. Photographs of colonies were taken at 
several magnifications. The experiment was performed several times to ensure 
reproducibility of different colony morphotypes. 
 
2.8 Anaylsis of biofilm formation  
 
Cultures were grown to an OD600nm ~ 0.5, as described above for most 
experiments, and were diluted 10X. A volume of 5 ml 7H9 broth was placed in 
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each well of a 6-well cell culture multidish (Nunclon Delta, Thermo Fisher 
Scientific). Each well was inoculated with 20 µl diluted culture of each strain and 
incubated at 30˚C, without shaking, for 7 days. Biofilm formation was determined 
by monitoring the formation of a thick pellicle of bacterial growth at the liquid-air 
interface as previously described (Ojha, et al., 2008). The experiment was 
performed at least three times to ensure biological reproducibility. 
 
2.9 Analysis of cell morphology by scanning electron microscopy 
 
M. smegmatis strains were grown to an OD600nm ~ 0.5, as described above, and 
the cells were harvested by centrifugation (4500 rpm; Allegra X-22, Beckman 
Coulter) for 10 min. The cell pellets were washed once in Phosphate buffer saline 
(PBS - 137 mM NaCl, 2.7 mM KCl, 10 mM Phosphate buffer solution, pH 7.4) by 
re-suspension and centrifugation. The cells were then re-suspended and fixed in 
the same buffer containing 2.5% glutaraldehyde overnight at 4˚C. The cells were 
washed again in PBS and dehydrated with increasing concentrations of ethanol 
for 10 min. Ethanol concentration used were 30%, 50%, 70%, 90% and 100%. A 
few drops of the absolute ethanol-cell suspension was placed on stubs and 
allowed to air-dry. The dried samples were coated with carbon and gold 
sputtering and analyzed with a Nova-200 FIB scanning electron microscope.     
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3. Results 
 
3.1 Bioinformatics analysis of rpf-like genes in M. smegmatis 
 
Several studies report the presence of multiple rpf-like genes in a variety of 
different bacterial and Firmicute species (Mukamolova, et al., 1998, Mukamolova, 
et al., 1999, Mukamolova, et al., 2002, Ravagnani, et al., 2005, Mukamolova, et 
al., 2006), suggesting that the multiplicity of Rpf homologues may play an 
important role in bacterial physiology.  
 
 
 
  
Figure 7: A schematic representation of the genomic organization of rpf-like genes in M. 
smegmatis (M. smeg) compared to rpf-like genes of M. tuberculosis (TB).  
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In this study, bioinformatics analysis was conducted to determine the number of 
rpf-like genes in M. smegmatis and the homology to their M. tuberculosis counter 
parts, Figure 7. Bioinformatics analysis, with the use of ACT (Artemis 
Comparison Tool), revealed that four rpf genes exist in M. smegmatis (Figure7) 
as opposed to the five identified in M. tuberculosis (Mukamolova, et al., 1998). M. 
smegmatis lacks a homologue for rpfD from M. tuberculosis. In terms of the 
arrangement of genes, both M. smegmatis and M. tuberculosis rpfA and rpfB 
genes are in the same genomic context (Figure7). The rpfA gene in both 
organisms is flanked by various Molybdenum cofactor biosynthesis genes. 
Similarly, genes upstream and downstream of rpfB are comparably arranged in 
both organisms. However, the rpfC and rpfE genes lie in different contexts in M. 
smegmatis and M. tuberculosis, Figure 7. In M. tuberculosis, rpfC and rpfE are 
located at distinct, separate chromosomal loci. However, in M. smegmatis these 
genes are proximal to each other and separated by only a short fragment (566 
bp) of intervening sequence that encodes a putative hypothetical protein with no 
known homologues.   
 
In M. smegmatis; it is probable that rpfA is transcribed from a monocistronic 
mRNA message as previously noted for M. tuberculosis (Tufariello, et al., 2004). 
In contrast, rpfB is part of a polycistronic message together with ksgA and 
MSMEG_5440 which encode a dimethyladenosine transferase and a 
deoxyribonuclease respectively. This has also been demonstrated in M. 
tuberculosis (Tufariello, et al., 2004). It is unlikely that the rpfC and rpfE genes 
are under the control of one promoter since there is an intermediate gene, 
MSMEG_4642, which is transcribed in the opposite direction to these rpf 
homologues. The MSMEG_4642 open reading frame extends into rpfC by 145 
bp, this gene is predicted to encode for a protein of unknown function. BlastP 
analysis of MSMEG_4642 does not reveal any significant hits against the non-
redundant database. Hence, we currently cannot ascribe a function to this protein 
nor confirm that the gene annotation is correct.  
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The overall amino acid sequence homology between M. smegmatis and M. 
tuberculosis was high for all Rpf proteins, Figure 8. RpfE ranked highest with 
80% sequence identity between the two organisms, while 65% sequence 
similarity was observed for RpfC. A 67% and 78% sequence identity was 
observed for RpfA and RpfB respectively.  
 
 
RpfA 
 
 
RpfB 
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Figure 8: Comparative amino acid sequence alignment of the Rpf proteins in M. 
smegmatis and M. tuberculosis. The protein sequences shown above for RpfA have 
been omitted, in the Blast search, for the last few hundred amino acid residues probably 
due to the inability of the sequences to align in the correct manner for the organisms in 
question, in this case the conserved Rpf domain is shown. Colour-coded sequences: Rpf 
domain (red), conserved cysteine residue (blue), conserved catalytic glutamate residue 
(light blue), DUF 348 Superfamily domain (purple), G5 Superfamily domain (green), 
glycine residues (yellow). 
 
 
As is observed in Figure 8, the Rpf domain (highlighted in red), which is a 
characteristic feature for all the Rpf proteins in both organisms, retains one of a 
pair of cysteine residues (blue) and the catalytic glutamate residue (light blue). 
The other cysteine residue is located outside the Rpf domain and is proposed to 
be involved in the formation of a disulphide bridge (Mukamolova, et al., 2006). 
Interestingly, the Rpf domain is positioned C-terminally in all the Rpfs with the 
exception of RpfA, a feature originally observed in M. tuberculosis (Mukamolova, 
et al., 2002). The significance of this is unknown but may be due to the presence 
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of a signal sequence (with associated post-translational cleavage) at the N-
terminus. M. smegmatis RpfC and RpfE are 153 and 107 amino acid residue 
proteins respectively, which are the smallest of all the Rpfs. Moreover, 
approximately 62% of M. smegmatis RpfE is comprised of the Rpf domain. One 
of the largest and more complex Rpfs is RpfB, which consists of 375 amino acid 
residues in M. smegmatis and retains other domains in addition to the conserved 
Rpf domain. Most noteworthy is the DUF 348 superfamily domain; DUF’s 
(Domains of Unknown Function) are essentially large groups of protein families 
with unknown function available in the Pfam database. These families may 
represent one or more protein domain(s) and are numbered in order of 
submission to the database (Bateman, et al., 2010). 
 
3.1.1 M. smegmatis Rpf-like proteins are secreted signal peptides  
 
The M. tuberculosis Rpfs are predicted to be secreted peptides, as evidenced by 
the presence of secretory signal sequences at the N-terminus (Mukamolova, et 
al., 1998). It is highly likely that the M. smegmatis Rpf-like proteins are also 
secreted, especially since a high protein sequence similarity is observed between 
the homologues in both organisms (Figure 8). This hypothesis was further 
explored with bioinformatics analysis using SignalP, a program that is able to 
identify secreted signals.  
 
The M. smegmatis Rpf-like proteins are secreted as predicted by SignalP 4.0 
server. SignalP 4.0 server predicts the presence of signal peptide sequences and 
cleavage sites within the amino acid sequence; furthermore it predicts the 
cleavage site position. Three different scores (C, S, Y) are used in the graphical 
output from SignalP following submission of protein sequences to the server. 
These scores determine whether the protein is a signal peptide and also 
localizes the cleavage site. All three scores are reported for every amino acid 
position in the sequence; the C-score (cleavage site score) should have a 
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significantly high value at the cleavage site, while the S-score should display high 
values at every amino acid that constructs the signal peptide.  
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Figure 9: Signal peptide prediction and localization of signal peptide cleavage sites 
within the M. smegmatis Rpf-like protein sequences. 
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A few high-peaking C-scores (red vertical lines) can be reported in a single 
sequence, as depicted above in Figure 9, and it is thus essential to determine 
which one is the actual cleavage site. The Y-score is assigned for the above 
task; it is a combination of the C- and S-scores resulting in a more accurate 
cleavage site prediction. Low values (below the threshold line) for all scores 
represent a non-secretory protein. 
 
In our analysis shown in Figure 9, three of the four M. smegmatis Rpf-like 
proteins are predicted to be signal peptides, whereas RpfB is not. The sole 
reason for a negative signal peptide prediction for RpfB is due to the fact that the 
protein is a lipoprotein and prokaryotic lipoproteins cleavage sites cannot be 
predicted with the use of SignalP. Lipoproteins are processed by specific signal 
peptidases, Lsp or signal peptidase II (Sander, et al., 2004, Denham, et al., 
2008), whereas the SignalP server reports predictions based on signal peptides 
processed by signal peptidase I. A more appropriate server for prokaryotic 
lipoproteins is LipoP; however it is only designed for Gram-negative bacteria and 
thus we conducted no further analysis on RpfB with this program.  
 
3.2 Construction of mutants defective for one or more rpf genes  
 
To assess the function of rpf-like genes in M. smegmatis, defined knockout 
mutants that lack one or more of these genes were constructed by two-step 
allelic mutagenesis using homologous recombination (Gordhan & Parish, 2001). 
The bioinformatics analysis provided the relevant insight into gene distribution 
and organization which allowed for the design of a suitable knockout strategy to 
delete rpfA and rpfB individually and in combination. These two particular genes 
were chosen for the following reasons: (I) the regulation of rpfA has been linked 
to the cAMP repressor in M. tuberculosis (Rickman, et al., 2005). cAMP is an 
important regulator of bacterial metabolism and this combined with the fact that 
RpfA is the largest of all Rpfs necessitated the inclusion of RpfA in our analysis 
(II) As mentioned previously, RpfB has been shown to interact with an essential 
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endopeptidase RipA and co-localizes with this protein to the cell poles. It was 
further demonstrated that RpfB synergizes with RipA in peptidoglycan 
degradation suggesting that RpfB plays an important role in cell growth hence its 
inclusion in our analysis.  
 
For gene deletion, primers were designed, using the program PRIMER 3, in such 
a way to create in-frame deletions of the rpf genes. The reading frame of the 
homologous upstream and downstream regions should not be disrupted in order 
to create an in-frame mutated copy of the target gene. The amplified homologous 
upstream and downstream regions flanking the deletion are directionally cloned 
into the multiple cloning sites (MCS) of p2NIL. A marker gene cassette from 
pGOAL19 (containing the lacZ gene– for blue colour selection, the sacB gene– 
for sucrose counter selection and the hygromycin resistance gene) is 
subsequently inserted into the PacI site of the p2NIL vector, thus completing the 
suicide plasmid construction. During allelic exchange mutagenesis, a mutated 
copy of the gene of interest is introduced into the chromosome with the use of 
suicide vectors. A recombination event between wild type and mutant allele gives 
rise to a strain with both gene copies, while two recombination events result in 
the replacement of the wild type gene with the mutant copy. This two-step 
strategy for constructing M. smegmatis deletion mutants involves selection of 
blue, HygR and KmR transformants on solid media containing those antibiotics 
and X-gal. These have undergone a single recombination event are referred to 
as single cross-over (SCO) strains. A second recombination event is permitted to 
occur by growth of the abovementioned transformants under the same 
conditions. The cells are further grown and selected on solid media containing 
sucrose and X-gal; and the white sucroseR clones represent potential double 
cross-over strains (DCO), the deletion mutants. 
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3.2.1 Suicide delivery vector construction 
 
3.2.1.1 Polymerase chain reaction (PCR) 
 
With the use of the designed primers, PCR was performed in order to amplify 
upstream and downstream regions of the rpf genes. This is illustrated below in 
Figure 10.  
 
 
 
rpfA moaE
MSMEG
_5702 moaCMSMEG
_5699moaA
Deleted
1360 bp
913 bp 904 bp
US DS
rpfB MSMEG
_5440 metG
MSMEG
_5442ksgA
MSMEG
_5437ispE
MSMEG
_5435
Deleted
1076 bp
836 bp 729 bp
US DS
 
 
 
Figure 10: A schematic representation of the rpf regions amplified during PCR 
with specifically designed primers, and the resulting PCR fragments with 
expected sizes. Small arrows represent forward and reverse primers and the gene of 
interest is highlighted and labeled in red. US-upstream and DS-downstream regions. 
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Figure 11: PCR fragments amplified for rpfA. (A+B) Thermus aquaticus (Taq) PCR. 
(A) Upstream PCR products: Lane 1: Molecular weight marker III, lane 2: no sample 
loaded, lane 3: forward primer control, lane 4: reverse primer control, lane 5: Test 
reaction with upstream PCR product of interest (1 µl template - M. smegmatis genomic 
DNA), lane 6: no DNA control, lane 7: Test reaction with upstream PCR product (5 µl 
template DNA). (B) Downstream PCR products: Lane 1: III, lane 2: no sample loaded, 
lane 3: forward primer control, lane 4: reverse primer control, lane 5: Test reaction with 
downstream PCR product of interest (5µl template - M. smegmatis genomic DNA), lane 
6: no DNA control, lane 7: Test reaction with downstream PCR product (10µl template 
DNA). (C+D) Expand High Fidelity PCR amplification of upstream and downstream 
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regions for rpfA. (C) Upstream rpfA PCR products: Lane 1: III, lane 2: no sample 
loaded, lane 3: no DNA control, lane 4-6: Test reaction with upstream PCR products run 
in triplicate. (D) Downstream rpfA PCR products: Lane 1: III, lane 2: no sample loaded, 
lane 3: no DNA control, lane 4-7: Test reaction with downstream PCR products. 
 
 
The PCR products for the upstream and downstream homologous regions for 
deletion of rpfA; seen above in 1% agarose gels, Figure 11, were of the correct 
expected sizes. The upstream and downstream fragments were expected to be 
913 bp and 904 bp respectively, thus the PCR proved successful. All control 
reactions, including no DNA, forward primer only and reverse primer only, yielded 
the expected result with the exception of the reverse only control for the 
downstream fragment, gel B. However, in this case there was marginal 
amplification of fragments with similar sizes to the expected PCR product, 
suggesting that the majority of these bands were non-specific.  Initially, the PCR 
was carried out with Taq enzyme, seen in Figure 11 (A+B) in order to optimize 
conditions. Thereafter PCR proceeded with Expand High Fidelity enzyme, as the 
name suggests, preventing error-prone PCR or point mutations. In this regard, 
both upstream and downstream homologous fragments for rpfA were amplified 
successfully with the Expand enzyme. 
 
Similarly, the fragment sizes of both upstream and downstream rpfB PCR 
products were correct as is seen in Figure 12. The upstream and downstream 
fragments were expected to be 836 bp and 729 bp respectively, as observed in 
the gels below. PCR optimization was carried out with Taq enzyme; thereafter 
the PCR was repeated with Phusion enzyme to reduce any chances of possible 
point mutations introduced within the sequence of the PCR products. 
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Figure 12: PCR fragments amplified for rpfB homologous regions. (A) Taq PCR: 
Lane 1: Molecular weight marker III, lane 2; forward primer control, lane 3: reverse 
primer control, lane 4: Test reaction with upstream PCR product of interest (1µl template 
DNA), lane 5: no DNA control, lane 6: Test reaction with upstream PCR product of 
interest (5µl template DNA), lane 7: forward primer control, lane 8: reverse primer 
control, lane 9: Test reaction with downstream PCR product of interest (1µl template 
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DNA), lane 10: no DNA control, lane 11: Test reaction with downstream PCR product of 
interest (5µl template DNA). (B+C) PCR products amplified with Phusion PCR. 
(B)Upstream PCR fragments: Lane 1: no DNA control, lane 2-4: Test reaction with 
upstream PCR products, lane 5: no sample loaded, lane 6: III. (C) Downstream PCR-
amplified fragments: Lane 1: III, lane 2: no sample loaded, lane 3: no DNA control, 
lane 4-6: Test reaction with downstream PCR products.
 
Non-specific bands were observed for the reverse primer control during 
optimization; Figure 12 A, lane 3, and were also present in the test reactions (gel 
A, lane 4 and 6) for upstream rpfB fragment amplification. Further optimization 
reduced and removed amplification of these non-specific bands, gel B and gel C 
respectively. All other control and test reactions yielded the expected results for 
both upstream and downstream rpfB fragments. The addition of 5 l template M. 
smegmatis DNA provided marginally better yields of PCR product. Amplification 
of both upstream and downstream rpfB regions was thus successful. 
 
3.2.1.2 Cloning of upstream and downstream homologous regions 
 
The abovementioned upstream and downstream PCR fragments, purified from 
gels, were cloned separately into carrier plasmid vectors. The carrier plasmid 
vectors used in this study were pBluescript and pGEM3Zf (+); where pBluescript 
was used as carrier vector for rpfB upstream and downstream fragments, 
whereas pGEM3Zf (+) was used for rpfA fragment cloning.  
 
Expand High Fidelity enzyme produces T-overhangs in the PCR fragments thus 
this was the reason pGEM-TEazy kit, which utilizes these overhangs to facilitate 
cloning, was suitable for cloning. The pGEM vector in this kit came ready for use 
and no further preparation was required unlike pBluescript. Phusion enzyme 
produces blunt ends in its PCR products and pBluescript was appropriate for 
facilitating such cloning. The different High Fidelity enzymes were used for 
different rpf gene region cloning due to availability of either enzyme at the time of 
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cloning. Both these vectors allow for blue/white colony selection, due to the 
presence of a lacZ gene within the plasmid, which is useful in determining 
whether cloning is successful or not. The lacZ gene expresses -galactosidase 
and in the presence of 5-bromo-4-chloro-3-indolyl--D-galactopyranoside (X-gal), 
E. coli colonies turn blue. In the case of pBluescript, SmaI, a blunt cutter, was the 
appropriate choice of enzyme for cloning, and the SmaI site is located within the 
multiple cloning sites (MCS) within the lacZ gene sequences. Cloned fragments 
at this site disrupt the lacZ gene, thus rendering the resulting protein inactive. 
Hence, successful cloning, in this case, results in white colonies. 
 
For cloning into pBluescript, the vector was digested with SmaI and separated on 
a 1% agarose gel, shown in Figure 13.  
 
3530 bp
2027 bp
1904 bp
1         2         3        4         5         6
 
Figure 13: pBluescript carrier plasmid vector linearized with SmaI enzyme. Lane 1: 
Molecular weight marker III, lane 2:  no sample loaded, lane 3: uncut plasmid, lane 4-
6: SmaI- linearized plasmid. 
 
The vector size is 2964 bp which corresponded to the size observed on the gel 
shown in Figure 13, lanes 4-6. This band was excised and purified and purified 
rpfB upstream and downstream homologous PCR fragments (Figure 12 B+C) 
were ligated to the vector by blunt cloning and transformed into E. coli DH5  
cells, followed by the selection and screening of white colonies. 
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Similarly, the rpfA upstream and downstream homologous regions were cloned 
into pGEM (preparation of the plasmid was not required as explained earlier) in 
an identical manner and E. coli cells were transformed with the construct. 
 
In both cases screening of numerous white clones, selected on Amp 100µg/ml, 
was initially undertaken by PCR (gels not shown) to confirm whether cloning was 
successful for both rpfA and rpfB intermediate constructs. Both white and blue 
colonies selected from LA plates were re-suspended in LB and the cell 
suspension was used as template DNA for the PCR reaction. Indeed the cloning 
was successful as was evidenced by the presence of fragments generated by 
PCR with observed sizes corresponding to expected sizes of upstream and 
downstream homologous regions for both genes. Selected blue colonies were 
used as a control, since they represented clones in which cloning was 
unsuccessful. Therefore no PCR product was expected from blue colonies as 
they did not contain the construct. Positive clones were selected for further 
screening and cloning purposes.  
 
As shown in Table 2 (section 2.4.1), the primers used to amplify the upstream 
and downstream homologous regions were designed in such a way to include 
restriction enzyme recognition sequences; where Asp718 and BglII restriction 
sites were present on either ends of upstream PCR fragments, likewise BglII and 
HindIII restriction sites on either sides of downstream PCR DNA fragments for 
cloning purposes.    
 
Plasmid DNA was extracted from PCR-screened, white colonies, and digested 
with the restriction enzymes mentioned above to ensure that the correct 
fragments and expected restriction sites were present in these vectors. As shown 
in Figure 14, for one clone from each cloning, all sizes observed corresponded to 
those expected for the upstream and downstream homologous regions. This 
served as further confirmation for the success of these cloning steps. 
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Figure 14: rpfA and rpfB constructs digested with appropriate enzymes releasing 
the cloned insert. (A) pBUrpfB and pBDrpfB constructs: Lane 1: Molecular weight 
marker III, lane 2: no sample loaded, lane 3: undigested plasmid, lane 4: BglII/HindIII 
double digestion releasing the downstream rpfB homologous fragment, lane 5: no 
sample loaded, lane 6: undigested plasmid, lane 7: Asp718/BglII-digested construct 
releasing upstream fragment, lane 8: no sample loaded. (B) pGUrpfA and pGDrpfA 
constructs (loaded on gel in duplicate): Lane 1: III, lane 2: no sample loaded, lane 3 & 
5: Asp718/BglII-digested construct releasing upstream fragment, lane 4 & 6: no sample 
loaded, lane 7 & 9: BglII/HindIII-digested plasmid releasing downstream fragment, lane 
8: no sample loaded. 
 
Fragments shown in Figure 14, indicated by red arrows with corresponding sizes 
confirmed the integrity of the clones. The DNA concentration yielded in gel B, 
lane 7 was low, which was not a matter of concern since the same DNA 
extracted from another clone yielded a good concentration as observed in lane 9. 
Sequencing of the above constructs confirmed their identity and indicated that no 
point mutations had occurred in the rpfA and rpfB upstream and downstream 
homologous sequences during PCR amplification. Hence these fragments could 
be used for the next phase of suicide vector construction. 
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3.2.1.3 Three-way cloning to create deletion alleles 
 
Three-way cloning involves simultaneous cloning of both upstream and 
downstream fragments into the p2NIL vector, a vector specifically developed for 
gene knockout in mycobacteria (Parish & Stoker, 2000). The partial sequence for 
this vector has been provided by the researchers who have generated it, 
however, it has been noted that there are several unmapped restriction sites.  
 
The vector was prepared and digested with appropriate enzymes for directional 
cloning, outlined in Figure 15. In this particular case, the vector was linearized 
with Asp718/HindIII to create the linear vector required for cloning, Figure 16. As 
a control for restriction digestion, the vector was also digested individually with 
these enzymes to ensure that each enzyme gave complete digestion of the same 
preparation of vector. These controls confirm that the enzymes would digest the 
vector in the double digest reaction.  
 
US
Asp718 BglII
DS
BglII HindIII
Asp718 HindIII
US DS
Asp718 HindIII
Directional cloning
p2NIL
  
Figure 15: Schematic showing three-way cloning resulting in simultaneous ligation of 
upstream and downstream homologous regions to p2NIL knockout vector by directional 
cloning.    
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The cloning was directional, as the name suggests where the Asp718 end of the 
upstream fragment and the HindIII end of the downstream fragment 
simultaneously ligate to the compatible ends of the Asp718/HindIII double-
digested p2NIL vector. The fragments ligate to each other since they both have 
BglII compatible ends, as illustrated in Figure 15. 
 
The size of the p2NIL vector is 4753 bp and this corresponded to the linearized 
vector observed in Figure 16, in lane 3 and 4. The circular, undigested p2NIL 
plasmid migrated ahead of the linear plasmid due to the fact that it was 
supercoiled and thus migrated faster. The vector digested with both enzymes 
was expected to yield a 4436 bp vector backbone and a 317 bp fragment which 
is released from the vector.  
 
 
 
Figure 16: p2NIL plasmid vector digested with appropriate enzymes for cloning 
purposes. Lane 1: Molecular weight marker III, lane 2: undigested vector, lane 3: 
HindIII-digested vector, lane 4: Asp718-digested plasmid, lane 5-8: Asp718/HindIII 
double-digested p2NIL vector. 
 
As observed in Figure 16, lane 5-8, the vector backbone DNA bands were 
slightly smaller to those seen in lane 3 and 4 and therefore corresponded to the 
size expected. Furthermore, small faint bands were released from the digestions 
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as indicated by the red arrow and the expected band sizes were 317 bp in 
accordance to what was observed from the gel. These digests confirm the 
integrity of the vector used for cloning. With regards to the inserts, the upstream 
and downstream homologous fragments were digested from intermediate vectors 
with the restriction enzymes mentioned above, Figure 17. The bands 
corresponding to the expected sizes (shown in Figure 14 and in Figure 17) were 
purified and simultaneously cloned into the purified 4436 bp p2NIL fragment. 
 
3530 bp
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1       2       3       4       5       6      7        8
3530 bp
2027 bp
947 bp
831 bp
1       2       3       4        5      6       7       8
A B
 
 
Figure 17: Upstream and downstream homologous rpf fragments digested from 
replicating vectors. (A) rpfA homologous regions released from pGEM: Lane 1: 
Molecular weight marker III, lane 2-4: Upstream fragment released by Asp718/BglII 
digestions, lane 5: no sample loaded, lane 6-8: BglII/HindIII digestions releasing 
downstream fragment. (B) pBluescript-released rpfB homologous fragments: Lane 1: 
III, lane 2-4: Asp718/BglII digestions releasing the upstream fragment, lane 5: no 
sample loaded, lane 6-8: Downstream fragment released by BglII/HindIII digestions.  
 
 
E. coli DH5 cells were transformed with the ligation and clones were selected 
on LA containing Km 50 ug/ml. Selected clones were initially screened by PCR 
(gels not shown), using primers to amplify the upstream homologous regions for 
both rpfA and rpfB. Each selected colony was re-suspended in LB and the cell 
suspension was used as template DNA in the PCR reaction. The presence of 
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PCR products with the expected upstream fragment size inferred that the three-
way cloning was successful, since it would be impossible to clone the upstream 
region only without the downstream region due to compatible ends.  
A single PCR-positive clone was selected for each p2NIL knockout construct 
(pNRPFA or pNRPFB) for further restriction mapping, to confirm whether the 
three-way cloning was indeed correct. 
 
Table 4: Restriction mapping for pNRPFA 
Enzyme Expected fragment sizes (bp) 
PvuI 2901, 1022, 1683 
MluI 4045, 1561 
BglII/HindIII 890, 4716 
ClaI 2166, 3440 
Asp718/BglII 899, 4707 
Asp718/HindIII 1789, 3817 
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Figure 18: Restriction mapping of the pNRPFA construct shown alongside its 
map. (A) Restriction digestions with various enzymes: Lane 1: Molecular weight marker 
 
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III, lane 2: ClaI, lane 3: Asp718/BglII, lane 4: Asp718/HindIII, lane 5: MluI, lane 6: 
BglII/HindIII, lane 7: PvuI, lane 8: VI. (B) pNRPFA map showing cloned upstream and 
downstream rpfA regions into p2NIL. 
 
The restriction mapping of pNRPFA (Figure 18) with ClaI, Asp718/BglII, 
Asp718/HindIII, MluI, and BglII/HindIII all gave the expected fragments. One 
digestion gave unexpected results; three fragments were expected from the PvuI 
digestion and four fragments were observed. In this case the expected 1022 bp 
and 1683 bp fragments (which are internal to the homologous regions cloned) 
were observed however, the 2901 bp vector-containing band was digested into 
two smaller fragments suggesting the presence of an unmapped PvuI site in the 
vector or new site inadvertently introduced during the cloning through vector 
backbone rearrangement.  
 
Table 5: pNRPFB restriction mapping 
Enzyme Expected fragment sizes (bp) 
NruI 3321, 2033 
BglII/HindIII 715, 4639 
PstI 4254, 1100 
StuI 748, 4606 
PvuII 953, 4401 
PvuI 2722, 938, 1694 
 
 
Restriction mapping of the pNRPFB clone with StuI, PvuII, PvuI, NruI and 
BglII/HindIII all yielded the expected fragment sizes, Figure 19. In some cases, 
digestions were repeated to ensure reproducibility (Figure 19B). The PvuII digest 
in lane 6 was incomplete, however, a complete digest for this enzyme with 
pNRPFB is shown in Figure 19A, lane 5– which yielded the expected sizes. The 
PstI digest however, gave an inconsistent result, with three fragments instead of 
the expected two bands. 
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Figure 19: pNRPFB restriction mapping. (A) Lane 1: Molecular weight marker III, 
lane 2: no sample loaded, lane 3: PstI, lane 4: StuI, lane 5: PvuII, lane 6: PvuI, lane 7: 
no sample loaded, lane 8: IV. (B) Lane 1: III, lane 2: NruI, lane 3: BglII/HindIII, lane 4: 
PstI, lane 5: StuI, lane 6: PvuII, lane 7: PvuI, lane 8: IV. (C) pNRPFB map. 
 
 
In this case, the additional fragment would be due to an unmapped PstI site at 
the vector-insert junction which most likely seems to have been introduced 
through the cloning process. The restriction mapping of both constructs yielded 
the expected fragments confirming the integrity of these clones, which were then 
used for the next step of suicide vector construction. 
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3.2.1.4 Completion of the suicide delivery vector: Cloning of selectable and 
counter selectable markers- PacI cassette cloning 
 
The final stage in the construction of the suicide vector involves cloning of the 
PacI cassette from pGOAL19 plasmid vector into the p2NIL constructs 
(pNRPFA and pNRPFB). The p2NIL knockout construct (pNRPFA and 
pNRPFB) clones were re-grown and extracted plasmid was linearized with PacI 
enzyme. At the same time, pGOAL19 was prepared and digested with PacI 
enzyme which resulted in the release of the PacI cassette. The PacI cassette 
carries the sacB, lacZ and hygromycin resistant genes, enabling for ease of 
selection and counter-selection. 
 
 
 
Figure 20: PacI linearized pNRPFA and pNRPFB constructs. Lane 1: Molecular 
weight marker III, lane 2: uncut pNRPFA, lane 3: no sample loaded, lane 4: PacI 
digested pNRPFA, lane 5: no sample loaded, lane 6: uncut pNRPFB, lane 7: no 
sample loaded, lane 8: PacI digested pNRPFB. 
 
The expected sizes of the linear pNRPFA and pNRPFB were 5606 bp and 
5354 bp respectively and this corresponded to what was observed in the gel; 
Figure 20, lane 4 and 8.  
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The PacI cassette is a large fragment carried in pGOAL19 plasmid vector which 
is 7939 bp and according to what was observed in Figure 21 below, the larger 
fragment corresponded to the PacI cassette fragment size. The linear pNRPFA 
and pNRPFB constructs and the PacI cassette were purified from the gels in 
preparation for cloning. 
 
 
 
 
Figure 21: PacI cassette isolation from pGOAL19 plasmid vector. Lane 1: Molecular 
weight marker III, lane 2: no sample loaded, lane 3: uncut plasmid vector, lane 4: no 
sample loaded, lane 5-7: PacI digested pGOAL19. 
 
The PacI cassette was cloned into the p2NIL knockout constructs and 
transformed into E. coli DH5 cells. Colonies were selected on Km at 50 µg/ml 
LA containing X-gal, and grown slowly to prevent rearrangements since this 
would be a large construct. Selected blue colonies grown in broth containing Km 
at 50 µg/ml were serially diluted and further screened on Km at 50 µg/ml LA with 
and without 5% sucrose. The sacB gene within the PacI cassette expresses an 
enzyme; levansucrase which is responsible for the conversion of sucrose to 
levan which is toxic to bacteria thereby resulting in cell death. It was thus 
expected to observe killing on sucrose-containing LA and normal growth on LA 
lacking sucrose. The observation confirms that the integrity of suicide vectors 
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had been maintained during growth. All selected clones were observed to be 
sucrose sensitive as described above, providing confirmation that gross 
rearrangements in marker genes had not occurred. Furthermore, restriction 
mapping was carried out to ascertain that the cloning was correct thus extracted 
plasmid was restricted with various enzymes and viewed on 1% agarose gels. 
 
Table 6: Restriction mapping of rpfA suicide vector (pSVRPFA). 
Enzyme Expected fragment sizes (bp) 
ClaI 3105, 337, 1386, 1958, 2166, 4593  
MluI 425, 780, 3567, 4045, 4728 
BglII/HindIII 7048, 739, 27, 3906, 890, 935 
PstI 5696, 2031, 3847, 1971 
SalI 6547, 3975, 678, 275, 2070 
XhoI 2293, 340, 7175, 2417, 1320 
 
21226 bp
2027 bp
1584 bp
1375 bp
1904 bp
947 bp
831 bp
1     2    3     4     5     6     7    8
2176 bp
1766 bp
1230 bp
1033 bp
653 bp
517 bp
pSV   RPFA
13545 bps
BglII 36
PstI 78
SalI 1291
PstI 2109
ClaI 3001
MluI 3480
MluI 4260
MluI 4685
XhoI 5265
XhoI 5605
ClaI 6106
ClaI 6443
HindIII 7084
PstI 7805
HindIII 7823
ClaI 7829
SalI 7838
HindIII 7850
XhoI 7898
MluI 8056
ClaI 9787
XhoI 9879
PstI 11738
HindIII 11756
SalI 11813
ClaI 11953
MluI 12101
XhoI 12296
SalI 12491
BglII 12646
SalI 12766
hyg
85lacZ
sacB
aph
'lacZ-a'
DS 
US
4268 bp
3530 bp
 
 
Figure 22: pSVRPFA restricted with various enzymes for confirmation of suicide 
vector integrity. Suicide delivery vector map shown alongside restriction mapping. 
 
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Digestions: Lane 1: Molecular weight marker III, lane 2: BglII/HindIII, lane 3: ClaI, lane 
4: MluI, lane 5: PstI, lane 6: SalI, lane 7: XhoI, lane 8: VI. 
 
Restriction analysis, seen above in Figure 22, with BglII/HindIII, ClaI and MluI 
yielded the correct sizes. However, cutting with SalI, XhoI and PstI indicated that 
some vector rearrangements had occurred. We further analyzed this by checking 
the functionality of the markers and were able to select kmR blue colonies 
confirming that lacZ and kmR genes were intact. Furthermore the vector was 
sucrose sensitive in E.coli (data not shown) confirming that the sacB gene was 
functional. Extensive sequencing revealed that the fragments for the deletion 
allele were correct. Hence, this vector was used for mutant construction since the 
final allelic exchange mutant would not have any vector sequence.  
 
Table 7: rpfB suicide vector (pSVRPFB) restriction mapping. 
Enzyme Expected fragment sizes (bp) 
NruI 4954, 4356, 3321, 662 
PstI 2031, 5696, 3933, 1100, 533 
ClaI 3105, 337, 1386, 1958, 2449, 4058 
SalI 6547, 6746 
BglII/HindIII 7048, 739, 27, 3906, 715, 858 
XhoI 340, 2293, 1981, 2432, 6247 
 
 
Similarly, the digestions observed in Figure 23 indicated rearrangement events 
within the construct. As in the case with pSVRPFA restriction mapping, Figure 
22, fragments in some of the digestions were either slightly larger, smaller or 
absent. Generally in all cases both for pSVRPFA and pSVRPFB, digestions 
that gave unexpected results always mapped to a p2NIL vector site. The suicide 
vectors were used for mutant construction since the inconsistency mapped to the 
vector backbone and not the deletion allele. Extensive restriction and sequence 
analysis of the mutant allele revealed no problems in this region. 
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Figure 23: Restriction mapping of pSVRPFB for plasmid integrity confirmation. 
pSVRPFB map shown alongside. Digestions: Lane 1: Molecular weight marker III, 
lane 2: BglII/HindIII, lane 3: ClaI, lane 4: NruI, lane 5: PstI, lane 6: SalI, lane 7: XhoI, 
lane 8: VI. 
 
 
In parallel, a new strategy was therefore devised in efforts to avoid 
rearrangements; pGEM was employed as vector in the construction of the 
suicide vectors thereby replacing p2NIL. The pGEM vector was prepared and 
digested with Asp718/HindIII simultaneously for three-way cloning as described 
earlier for p2NIL, section 3.2.1.3. The expected pGEM vector size digested with 
Asp718 and HindIII was 3160 bp, which corresponded to what was observed on 
the gel as indicated with the red arrow, Figure 24. A 39 bp fragment was 
released from the abovementioned digestion and was visible as faint bands at 
the base of the gel. The upstream and downstream rpf regions were cloned into 
the Asp718 and HindIII sites of digested pGEM as previously described and 
illustrated in Figure 15, and the pGEM knockout constructs were mapped by 
restriction digestion to confirm that the cloning was indeed correct. 
 
 
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Figure 24: pGEM plasmid vector restricted with appropriate enzymes in 
preparation for three-way cloning. Lane 1: Molecular weight marker III, lane 2: no 
sample loaded, lane 3: uncut pGEM, lane 4: no sample loaded, lane 5-7: Asp718/HindIII 
digested vector. 
 
 
Table 8: Mapping of pGRPFA construct by restriction digestion. 
Enzyme Expected fragment sizes (bp) 
PvuI 1022, 2274, 1352, 301 
PvuII 1185, 2820, 944 
SalI 275, 678, 3996 
NaeI 538, 10, 3463, 938 
SacI 273, 33, 353, 722, 3568 
Asp718/HindIII 1789, 3160 
 
 
The integrity of both pGRPFA and pGRPFB constructs was confirmed by 
restriction mapping as seen in Figures 25 and 26; all digestions were correct 
although one of the fragments observed in the NaeI digestion in Figure 25, lane 3 
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gave a slightly smaller band than expected. It was surprising that the restriction 
mapping made sense in pGEM whereas it did not in p2NIL, considering that the 
same upstream and downstream rpf regions were used in both cloning events. 
This confirmed previous suspicions that the p2NIL vector was unstable. 
 
 
 
Figure 25: Restriction mapping of pGRPFA construct shown alongside the 
knockout construct map. Digestions: Lane 1: Molecular weight marker III, lane 2: 
Asp718/HindIII, lane 3: NaeI, lane 4: PvuI, lane 5: PvuII, lane 6: SacI, lane 7: SalI, lane 
8: IV. 
 
 
Construction of suicide vectors in pGEM was an attractive option rather than in 
p2NIL since the vector was stable however, several attempts were made to clone 
the PacI cassette in pGRPFA and pGRPFB but proved unsuccessful. The 
pGEM strategy was abandoned and the p2NIL strategy was re-adopted. The 
cloned rpf regions in pGEM were digested out from the vector and cloned into 
p2NIL again, furthermore the PacI cassette was cloned into those constructs. 
 
 
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 Restriction mapping for the newly-made p2NIL knockout constructs (pNRPFA 
and pNRPFB) and suicide vectors (pSVRPFA and pSVRPFB) remained 
unchanged from previous cloning events.  
Table 9: pGRPFB restriction mapping. 
Enzyme Expected fragment sizes (bp) 
PvuII 953, 670, 2820, 254 
PvuI 938, 2095, 1352, 312 
SacII 570, 416, 3711 
AatII 2279, 2418 
Asp718/bglII 822, 3875 
Asp718/HindIII 1537, 3160 
 
 
 
 
Figure 26: pGRPFB restriction mapping shown with the construct map. 
Digestions: Lane 1: Molecular weight marker III, lane 2: AatII, lane 3: Asp718/BglII, 
lane 4: Asp718/HindIII, lane 5: PvuI, lane 6: PvuII, lane 7: SacII, lane 8: IV. 
 
Construction of a suicide delivery vector for rpfCE (MSMEG_4643/4643), where 
both genes are deleted simultaneously, proved impossible with the use of the 
 
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same strategy utilized in the construction of suicide vectors for rpfA 
(MSMEG_5700) and rpfB (MSMEG_5439). Construction of another suicide 
vector for rpfCE (Appendix C, Figure A1) using a different method was 
undertaken (by another member of the laboratory), which proved to be 
successful and this construct was generously provided for use in this study. 
 
3.2.2 Construction of single deletion mutants of M. smegmatis defective for 
rpfA and rpfB. 
 
In this study, gene knockout was achieved by two step allelic exchange 
mutagenesis using a suicide vector carrying selectable and counter selectable 
markers. For this process, the vector is electroporated in M. smegmatis followed 
by the selection of blue, HygR and KmR colonies. These transformants represent 
single cross-over integrants which are then grown in the presence of sucrose, a 
counter selectable marker, to facilitate the second cross-over event. The sacB 
gene, present in the vector, encodes for levanesucrose which converts sucrose 
into a toxic metabolite resulting in bacterial death. Hence, in the presence of 
sucrose, bacterial death facilitates the second cross-over event to expel the 
vector and associated toxicity. It is important to note that this second cross-over 
can result in incorporation of the mutant allele, or reconstitution of the wild type 
allele, Figure 27. Hence, further screening of sucrose-resistant white colonies is 
imperative.  
 
The pSVRPFA and pSVRPFB suicide delivery vectors were integrated into the 
genome of M. smegmatis mc2155 by electroporation. The blue, HygR and KmR 
clones were selected post electroporation and grown in 10 ml of 7H9 broth to an 
OD600nm of ~1 and plated in the presence of sucrose for counter-selection. 
White, sucrose resistant colonies were selected and the success of allelic 
exchange mutagenesis was determined by PCR using allelic-specific primers. As 
shown in Figure 28 (for rpfA), three primers were used and added to the PCR 
reaction together. The mutant allele was amplified by primers F1 and R2 (since 
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R1 sequence is deleted in this genetic background) to yield a 160 bp fragment 
and the wild type allele was amplified by F1 and R1 to yield a 300 bp fragment.  
 
Chromosome rpfA/rpfB/rpfC/rpfE
rpfA/rpfB/rpfC/rpfE
Marker genes
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single cross 
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Marker genes rpfA/rpfB/....rpfA/rpfB/….
sucR
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double cross 
over event 
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Figure 27: Construction of knockout mutants by two step allelic exchange mutagenesis. 
 
As shown in Figure 28, the allelic exchange mutagenesis yielded several mutant 
strains, with no wild type band visible. The controls in gel A of Figure 28 made it 
clear which bands were wild type or mutant DNA, and in some instances both 
wild type and mutant bands were observed for a sample (gel A, lane 10 and gel 
B, lane 7,8,11,12) which was indicative of single cross-over strains. The mutant 
band was expected to be smaller since the screening primers would only amplify 
regions flanking the deletion. Five rpfA mutants were identified from the screen. 
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Figure 28: Illustration of the screening process and identification of rpfA mutants 
using rpfA allelic-specific screening primers following allelic exchange 
mutagenesis. (A) Lane 1: Molecular weight marker VI, lane 2: No DNA control, lane 
3: pSVRPFA control, lane 4: wild type DNA control, lane 5-15: sucR M. smegmatis 
clone DNA. (B) Lane 1: VI, lane 2-12: sucR M. smegmatis clone DNA.  
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A similar screening strategy used to screen for rpfA mutants was applied for 
rpfB mutants as explained above. The mutant and wild type allele DNA bands 
were expected to be 160 bp and 300 bp respectively; the former being amplified 
by F1 and R2 primers, whereas the F1 and R1 primers amplifying the latter. 
Screening for rpfB mutants was performed twice, where only a single rpfB 
mutant was identified in the initial screen (gels not shown), further screening 
yielded two additional mutants (Figure 29,gel B lane 7 and 9). The clones 
corresponding to both rpfA and rpfB mutant DNA identified, shown in Figures 
28 and 29, were grown for future phenotypic characterization.  
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Figure 29: The identification of rpfB mutants resulting from the demonstrated 
screening strategy using rpfB allelic-specific screening primers, following allelic 
exchange mutagenesis. (A) Lane 1: Molecular weight marker VI, lane 2: No DNA 
control, lane 3: wild type DNA control, lane 4: pSVRPFB control, lane 5: no sample 
loaded, lane 6-15: sucR M. smegmatis clone DNA. (B) Lane 1: VI, lane 2: No DNA 
control, lane 3: wild type DNA control, lane 4: pSVRPFB control, lane 5: no sample 
loaded, lane 6-10: sucR M. smegmatis clone DNA.  
 
3.2.3 Construction of double and triple mutants of M. smegmatis defective 
for multiple rpf-like genes. 
 
Allelic exchange mutagenesis with wild type M. smegmatis, mc2155, yielded 
rpfA and rpfB single mutants. The multiplicity of rpf genes in M. smegmatis 
poses significant problems to dissecting individual function using gene deletion. 
Hence, strains defective for multiple rpf genes are required to understand 
collective or synergistic function. For this, the rpfB deletion mutation was 
introduced into the rpfA progenitor strain using the pSVRPFB suicide vector 
described above. The subsequent selection and PCR screening was conducted 
as described above. PCR screening, shown in Figure 30, of white sucR colonies 
to detect deletion of rpfB, in the rpfA deletion strain, indicated that several 
double mutants were generated using this method, these are clones in gel A 
lanes 6,8,11,12,15 and gel B lanes 7, 8, 9,12 and 13. Since the electroporations 
were performed in the background of an M. smegmatis strain lacking rpfA; it was 
expected that the PCR analysis of all the positive clones would reveal a deletion 
in rpfA. All the positive clones identified in Figure 30A and Figure 30B were 
hence analyzed for deletion of rpfA. As expected, all of these clones retain a 
deletion in rpfA, Figure 30C.  
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Figure 30: Identification of rpfA rpfB double mutants with the use of rpfB allelic-
specific screening primers in a rpfA genetic background, following allelic 
exchange mutagenesis. (A) Lane 1: Molecular weight marker VI, lane 2: no sample 
loaded, lane 3: No DNA control, lane 4: wild type DNA control, lane 5: SCO (single 
cross-over) DNA control, lane 6-15: sucR M. smegmatis clone DNA. (B) Lane 1: VI, 
lane 2: no sample loaded, lane 3: No DNA control, lane 4: wild type DNA control, lane 
5: SCO DNA control, lane 6-13: sucR M. smegmatis clone DNA. (C) Confirmation of the 
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rpfA genetic background using rpfA allelic-specific screening primers from identified 
clones with the rpfB gene deletion: Lane 1: molecular weight marker IV, lane 2: No 
DNA control, lane 3-4: wild type DNA control, lane 5: SCO DNA control, lane 6-15: sucR 
M. smegmatis clone DNA. 
 
 
Attempts to create suicide vectors for deletion of rpfC and rpfE were 
unsuccessful. A few problems were encountered in the attempted construction of 
the above suicide vectors; which included amplification of non-specific bands. 
Optimisation of PCR and re-designing primers for the abovementioned genes 
proved futile in efforts to resolve the amplification problem. It was, however, 
surprising that the amplicons obtained for both gene fragments were of the 
expected size yet the sequencing data did not validate the genes. However, a 
suicide delivery vector for rpfC and rpfE (Appendix C, Figure A1) was later 
constructed with the use of a different strategy, by Dr. Edith Machowski at the 
MMRU-CBTBR and was generously provided for use in this study to assist with 
creating further combinatorial deletion mutants. The above construct was 
introduced later in the study and integration of the vector into the wild type 
genetic background which would result in single rpfC and rpfE mutants was 
unsuccessful. No further attempts were made to obtain the single rpfC and rpfE 
mutants due to time constraints. Other combinatorial deletion mutants lacking 
rpfC and rpfE were successful and included in the study. This suicide vector was 
integrated in the rpfA rpfB double mutant followed by two step allelic exchange 
mutagenesis and screening as described above. PCR screening primers for rpfC 
and rpfE were designed in a manner similar to that for rpfA and rpfB and used for 
screening white, sucrose resistant colonies. The result of this screen, shown in 
Figure 31, indicate that six clones were identified to be rpfC deficient, Figure 31A, 
lane 8-12,15. Only 2 clones were found to be rpfE deficient as seen in Figure 
31B, lane 7 and 13. Thus 8 triple rpf mutants were identified from the screen, 6 
being rpfA rpfB rpfC and 2 being rpfA rpfB rpfE mutants, since these 
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genes were deleted in the background of a double rpfA rpfB M. smegmatis 
mutant strain.  
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Figure 31: The identification of rpfC and rpfE deficient genomic DNA in the rpfA 
rpfB double mutant genetic background using rpfC and rpfE allelic-specific 
primers following allelic exchange mutagenesis. (A) PCR screen with rpfC allelic-
specific primers: Lane 1: Molecular weight marker VI, lane 2: no sample loaded, lane 
3: No DNA control, lane 4: wild type DNA control, lane 5: SCO DNA control, lane 6: 
pSVRPFCE control, lane 7-15: sucR M. smegmatis clone DNA. (B) PCR screen with 
rpfE allelic-specific primers: Lane 1: VI, lane 2: no sample loaded, lane 3: No DNA 
control, lane 4: wild type DNA control, lane 5: SCO DNA control, lane 6: pSVRPFCE 
control, lane 7-15: sucR M. smegmatis clone DNA.  
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3.3 Southern blot analysis of mutant strains to further confirm genotype 
 
Southern blotting was necessary to validate the mutants identified in the PCR 
screening as these screens were insufficient alone to confirm that the mutants 
were indeed correct. It was therefore imperative to perform Southern blotting 
analysis using restriction sites outside of the regions of homology used for 
deletion mutagenesis to ensure site-specific integration of these mutational 
events. These analyses would confirm the integrity of the genomic region in 
question. Appropriate enzymes, with one of the sites being present outside the 
region of homology, were chosen and both wild type and the rpf mutant DNA was 
digested with the chosen enzymes. All regions, upstream and/or downstream, 
were analyzed and were confirmed to be indeed correct as all the expected 
fragment sizes corresponded to the observed fragments on the blots for both wild 
type and rpf mutants. 
For rpfA, as shown in Figure 32A, in the wild type background the PvuII sites are 
positioned 2966 bp apart at this locus and a 2966 bp fragment was expected 
from wild type genomic DNA, whereas a 1600 bp fragment was expected from 
the rpfA mutant DNA since 1366 bp internal sequences were deleted from rpfA. 
Southern blotting with a downstream probe confirmed this genotype, Figure 32A. 
An upstream probe was used for rpfB genotyping; as shown in Figure 32B the 
enzyme chosen for this region was PstI, which had 3 sites within the region. Two 
fragments were thus anticipated for wild type; 883 bp and 1040 bp fragments. 
However, one of the PstI sites was positioned within the deleted rpfB internal 
sequences and was therefore lost in the rpfB deletion strain. In the rpfB mutant 
background; the 883 bp fragment was therefore expected since those sites were 
unaffected by the deletion but a slightly larger fragment (1183 bp) was generated 
due to loss of the abovementioned site, which extended over to a fourth 
downstream PstI site in the DNA – southern blotting with the upstream region 
confirmed this genotype, Figure 32B. The rpfB deletion allele was further 
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genotyped with PvuII, for the downstream rpfB region. As shown in Figure 32C, a 
2142 bp common fragment was expected for wild type and rpfB mutant, while the 
2024 bp fragment observed for the wild type was reduced in size in the mutant 
due to a 1073 bp deletion of internal sequences resulting in a 951 bp fragment. 
Hence, despite some vector rearrangement, the suicide vectors created in this 
study were successfully used to construct site-specific, allelic exchange mutants, 
with no disruption/rearrangement of upstream and downstream regions in the 
chromosome. Similarly, MluI was used for genotyping the rpfC downstream 
region, Figure 32D. In the wild type background, a 1468 bp fragment was 
expected since two MluI sites were positioned 1468 bp apart in this gene region. 
The fragment size was reduced in rpfC mutant background due to 425 bp 
internal sequences being deleted.  
 
PvuII
rpfA moaE
MSMEG
_5702 moaCMSMEG
_5699moaA
Wt
MSMEG
_5697
MSMEG
_5704
PvuII
2966 bp
rpfA moaE
MSMEG
_5702 moaCMSMEG
_5699moaA
rpfA
MSMEG
_5697
MSMEG
_5704
PvuII PvuII
1600 bp
2966 bp
1600 bp   Probe
 
 
A 
95 
 
rpfB
MSMEG
_5440 metG
MSMEG
_5442ksgA
MSMEG
_5437ispE
Wt
883 bp 1040 bp
PstI PstI PstI PstI
rpfB
MSMEG
_5440 metG
MSMEG
_5442ksgA
MSMEG
_5437ispE
rpfB
PstI PstI PstI
883 bp 1183 bp
883 bp
1040 bp
1183 bp
A
1183 bp
1040 bp
883 bp
B
Probe
 
 
rpfB
MSMEG
_5440 metG
MSMEG
_5442ksgA
MSMEG
_5437ispE
Wt
PvuII PvuII PvuII
2024 bp 2142 bp
rpfB MSMEG
_5440 metG
MSMEG
_5442ksgA
MSMEG
_5437ispE
rpfB
PvuII PvuIIPvuII
951 bp 2142 bp
951 bp
2142 bp
2024 bp
Probe
 
B 
C 
96 
 
rpfCMSMEG
_4641
MSMEG
_4642 rpfE
MSMEG
_4644 orB
rpfC
MluI MluI
1043 bp
Probe
rpfC
MSMEG
_4641
MSMEG
_4642 rpfE
MSMEG
_4644 orB
Wt
MluIMluI
1468 bp
1468 bp
1043 bp
 
Figure 32: Genotyping of the upstream and/or downstream regions of the rpf 
mutants by Southern blot analysis. Genotyping: (A) rpfA downstream region, (B and 
C) rpfB upstream and downstream regions respectively, (D) rpfC downstream region. 
Figures not drawn to scale. 
 
3.4 Construction of complemented derivatives 
 
A previously constructed complementation vector by a member of the MMRU 
was included for use in this study. The pMRPFAB construct (Appendix C, Figure 
A2) is essentially an integration vector carrying both M. tuberculosis rpfA and 
rpfB genes with their native promoter regions. The construct was introduced into 
the rpfA rpfB double mutant by electroporation and the transformants were 
selected on Hyg 50 µg/ml. A complemented derivative strain was thus 
constructed, rpfA rpfB::pMVRPFAB, with an anticipated wild type phenotype. 
Reverse-engineering the double mutant genotype to expected wild type 
D 
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phenotypes served as confirmation that the observed mutant phenotypes were 
due to loss of these rpf genes.   
 
3.5 Phenotypic characterization of the rpf single and multiple mutants 
 
3.5.1 Growth kinetics of the single and multiple rpf mutants 
 
There is extensive evidence in the literature that deletion of rpf genes results in 
significant growth defects in other organisms. Hence, a comparative analysis of 
the growth characteristics of the wild type, rpf mutants and a complemented 
derivative was carried out. The different strains were grown at 37˚C in 
Middlebrook 7H9 broth supplemented with 0.02% tyloxapol to prevent clumping. 
Growth was monitored by optical density at 600nm (OD600nm) readings and 
colony forming unit (CFU) enumeration, every 3 hrs over a 33 hr period. No 
significant differences in growth were observed between wild type and the single 
mutants as observed by OD600nm and CFU counts on solid media. However, the 
double rpfA rpfB and triple rpfA rpfB rpfC mutants did display a marginal, 
statistically significant, extension of the lag phase as measured by OD600nm. 
These differences observed early in the growth curve were also noted in the CFU 
analysis, suggesting that the Rpfs are required for growth stimulation in early 
axenic culture. However, it should be noted that these differences were marginal 
and only restricted to early growth since no significant differences were noted 
after 24 hrs of growth in culture.  
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Figure 33: Growth characteristics of wild type in comparison to the rpf mutants 
and a complemented derivative. (A) Growth as determined by optical density 
99 
 
readings. (B) Cfu counts as a measure of growth. P-values were determined by the 
Student’s t-test. The results shown are an average of three independent experiments.  
 
The differences in growth attenuation obtained from the OD600nm readings did not 
correlate well with the CfU data reported in Figure 33B. In the CFU analysis, 
growth of the multiple deletion mutants was significantly different to wild type only 
at the eighteenth hr of growth as indicated on the graph. In general the CFU 
analysis gave a higher standard error when compared across experiments. This 
suggests that even though every attempt was made to standardize the 
experimental protocol and reagents, subtle differences between experiments 
may have affected the outcome. The complemented derivative (rpfA 
rpfB::pMVRPFAB), where functional copies of both rpfA and rpfB from M. 
tuberculosis were introduced into the rpfA rpfB mutant, grew comparably to 
wild type. This suggests that the marginal difference in growth obtained was due 
to deletion of rpf genes. In general, there was no observable growth phenotype 
for both the single rpfA and rpfB deletion mutants and the multiple mutants. What 
was observed to be a slightly prolonged lag phase by OD600nm readings, could 
have been an “apparent lag” although certain experimentation work is required to 
explore and confirm this.   
 
3.5.2 Bacterial clumping in liquid culture associated with rpfA gene deletion 
 
The slightly prolonged lag could have been due to bacterial clumping since it was 
noted that all strains lacking rpfA, displayed clumping in liquid cultures in 
stationary phase, Figure 34. The clumping (indicated by red arrows) observed for 
rpfA rpfB and rpfA rpfB rpfC cultures was pronounced when compared to 
the single rpfA mutant strain suggesting that progressive deletion of rpf genes in 
the rpfA mutant background reinforces this phenotype. The rpfA clumps were 
larger than those of the multiple mutants, which were observed smaller fine-
textured clumps resembling bread crumbs. It is possible that micro-clumps 
develop very early in the growth curve but these were not detectable with our 
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standard methods. Aggregation in several actinomycetes is an intrinsic response 
to increased stress, which may be exogenous such as external stimuli or 
endogenous as exemplified in this study by loss of important genes. However, a 
comparison is made to wild type in the extent of clumping due to loss of rpf 
genes in the mutants. 
 
The observed bacterial clumping phenotype was reversed back to wild type 
phenotype in the complemented derivative (rpfA rpfB::pMVRPFAB) as shown 
in Figure 34, indicating that the phenotype observed was indeed due to loss of 
the rpf genes.   
 
Wild type rpfA rpfB
rpfA rpfB rpfA rpfB rpfC rpfA rpfB::pMVRPFAB
 
 
Figure 34: Culture flasks showing bacterial clumping in 33-hour stationery phase 
cultures of single rpfA and multiple rpf mutants lacking an rpfA gene. This phenotype 
was observed consistently in all cultures grown in this study.  
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3.5.3 The multiple rpf deletion mutants display an increase in susceptibility 
to erythromycin and vancomycin 
 
Previous analysis of rpf deletion mutants in M. tuberculosis indicated that 
deletion of multiple rpf genes leads to increase in susceptibility to select drugs, 
including vancomycin, erythromycin and detergent (SDS) (Kana, et al., 2008, 
Kana, et al., 2010). Hence, it was anticipated that deletion of one or more rpf 
genes in M. smegmatis, may render the resulting strains susceptible to similar 
drugs and detergents. Other cell wall-targeting drugs (carbenicillin, D-
cycloserine) were also tested, since the rpf gene products act on the bacterial 
cell wall and deletion thereof may affect susceptibility to these cell wall-targeting 
antibiotics. Cultures of the six different strains, grown at OD600nm ~ 0.4, were 
tested for detergent and antibiotic sensitivity by serially diluting the culture and 
spotting 10 ul of each dilution on solid media containing drug/detergent, Figure 
35. 
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Figure 35: Drug and detergent susceptibility testing of the wild type, rpf 
mutants and a complemented derivative. (A) 0.001% SDS, (B) 0.005% SDS, 
(C) 2000 µg/ml carbenicillin, (D) 150 µg/ml D-cycloserine, (E) 10 µg/ml 
erythromycin, (F) 6 µg/ml vancomycin. Images shown after four days of 
incubation. The left and right panels represent the “no drug” control and drug or 
detergent testing respectively.  
 
All rpf mutant and wild type cells grew comparably in SDS at low concentrations 
as seen in Figure 35A, thus it was decided to increase the concentration. SDS is 
an anionic detergent which inhibits bacterial growth, like all detergents, by protein 
denaturation and insertion into the cell membrane. The concentration was 
increased five-fold in order to create a slightly more stressful environment to 
assess differences in growth between wild type and the rpf mutants. The 0.005% 
SDS concentration proved sufficient to result in significant death of the wild type 
strain, Figure 35B. Under these conditions, the double and triple rpf deletion 
mutants (rpfA rpfB and rpfA rpfB rpfC) displayed enhanced susceptibility, 
as indicated by red arrows in Figure 35B. In the undiluted spot, sparse growth 
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was observed for multiple mutants while a lawn was seen for wild type and single 
mutant cells; however this phenotype was abrogated with further incubation. The 
image was taken 4 days post-incubation and the observed phenotype 
disappeared following 2 days of further incubation.  
 
No significant differences in susceptibility were observed between wild type and 
rpf mutants with 2000 µg/ml carbenicillin as seen in Figure 35C. Carbenicillin is a 
-lactam antibiotic and acts to inhibit the process of cross-linking in the cell wall 
by binding to enzymes responsible for cross-linkage- a process important for cell 
wall synthesis. The concentration used was astoundingly high since 
mycobacteria in general are not highly susceptible to -lactam antibiotics due the 
presence of -lactamases (Hugonnet, et al., 2009, Sala, et al., 2009). Similarly, no 
significant differences were observed between all strains when tested on D-
cycloserine, all the mutants grew comparably to wild type as shown in Figure 
35D. D-cycloserine antibiotic acts by inhibiting cell wall synthesis but at very 
different levels to carbenicillin. The mode of action for this antibiotic is specific to 
inhibition of the formation and linking of D-alanine amino acid residues at the 
Lipid II peptide terminal end, Lipid II being a peptidoglycan precursor.   
 
An approximate 2 log increase in susceptibility to 10 µg/ml erythromycin and 6 
µg/ml vancomycin was observed for rpfA rpfB and rpfA rpfB rpfC, as 
indicated by the yellow rectangles in Figure 35E and 35F respectively when 
compared to wild type. Erythromycin, a macrolide, is bacteriostatic unlike 
vancomycin and it generally inhibits protein synthesis by binding in the 
polypeptide exit tunnel of the large subunit of the ribosome. Vancomycin is a 
glycopeptide antibiotic which prevents cell wall synthesis due to cross-linking 
interference in the peptidoglycan layer of the bacterial cell wall (Schilling, et al., 
2011). A reduction in susceptibility to both erythromycin and vancomycin was 
observed in the complemented double mutant (rpfA rpfB::pMVRPFAB), to 
levels similar to wild type, confirming that the increased susceptibility in this case 
was due to loss of rpf genes. Under normal conditions; the multiple mutants grew 
106 
 
throughout to the 105 dilution factor whereas under stressful conditions 
(antibiotics present), growth was only observed up to the 101. Thus growth of the 
multiple mutants was inhibited by at least four logs under stressful conditions. 
This indicates the weakened cell wall of the cells due to multiple rpf loss. 
 
3.5.4 Deletion of multiple rpf genes results in alterations in colony 
morphology. 
 
Since the rpf gene products act on the cell wall at the peptidoglycan layer, we 
postulated that deletion of rpf genes would result in changes in colony 
morphology. To test this, serially diluted cultures of all strains were spread on 
solid media and incubated for 5 days. The single mutant colonies, rpfA and 
rpfB, were comparable to wild type colonies since they retained the serpentine 
cording at the surface of the colony, which was marginally reduced in the rpfA 
mutant, Figure 36. However, significant differences in cording and colony 
morphology were observed for the multiple mutants; rpfA rpfB and rpfA rpfB 
rpfC. The cording effect was greatly reduced at the colony surface of rpfA 
rpfB and even more so with rpfA rpfB rpfC as shown in the inserts of Figure 
36. These colonies retained a smoother appearance with a halo-like periphery, 
and papillae at the centre.  
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Figure 36: Colony morphological changes as a result of successive rpf gene 
deletion. These phenotypes were consistently observed throughout the study. 
Logarithmic phase cultures were serially diluted and plated on Middlebrook 7H10 agar 
and incubated for 4 days.  
 
When rpfA rpfB was complemented with both rpfA and rpfB M. tuberculosis 
genes, rpfA rpfB::pMVRPFAB, the observed phenotype was reversed to wild 
type phenotype confirming that the phenotype was due solely to deletion of rpfA 
and rpfB genes. These results confirm that the rpf gene products have specific 
biological roles within the bacterial cell wall.  
 
3.5.5 Biofilm formation defects associated with multiple rpf gene deletions 
 
The changes in colony morphology, combined with the clumping of some strains 
in media prompted us to assess if there were any defects in biofilm formation for 
rpf deletion mutants. Biofilm formation requires complex interactions and 
signaling between the bacterial cells, thus the cell wall is an important factor in 
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the process. Biofilms were set up in tissue culture multi-well plates consisting six 
large wells, and each well contained 10X diluted culture at OD600nm~ 0.5 for each 
strain. All strains were standardized for inoculation by ensuring that equivalent 
starting OD600nm readings were accurate. Biofilm formation in this assay is 
measured by the formation of lush growth at the liquid-surface interface as seen 
in Figure 37 for the wild type strain (Ojha, et al., 2008).  
 
Wild type rpfA rpfB
rpfA rpfB rpfA rpfB rpfC rpfA rpfB::pMVRPFAB
 
 
Figure 37: Retarded biofilm formation in multiple rpf mutants. A 1:10 diluted log-
phase culture of the above strains was inoculated into fresh Middlebrook 7H9 medium 
and images were taken 7 days post-inoculation. The results observed represent three 
independent experiments. 
 
As seen in Figure 37, biofilm formation in the single mutants (rpfA and rpfB) 
was comparable to that observed for wild type, whereas rpfA rpfB and rpfA 
rpfB rpfC mutants displayed significantly retarded biofilm formation. The 
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complemented derivative, rpfA rpfB::pMVRPFAB, displayed a phenotype 
similar to that of the wild type, confirming the observed double mutant phenotype 
to be due solely to deletion of rpfA and rpfB genes.  
 
3.5.6 Cell morphological deformities resulting from multiple rpf deletion 
 
Previous observations from colony morphology alterations in the multiple rpf 
mutants, Figure 36, led us to speculate that such changes could be evidenced at 
the cellular level. Furthermore, the observed clumping in select (rpfA deficient 
strains) cultures also prompted the examination of all strains at the cell surface 
level using Scanning Electron Microscopy (SEM). It was initially suspected that 
all rpfA-depleted strains displayed a filamentous morphology since clumping in 
culture is often associated with filamentation (Hett, et al., 2008, Nguyen, et al., 
2010); however this was not the case as seen in Figure 38. Cultures were grown 
to OD600nm ~ 0.5 from overnight pre-cultures and subsequently prepared for SEM. 
M. smegmatis mc2155 (wild type) cells appear on electron micrographs as 
straight rods with a septum located at an asymmetrical position along the cell 
length. The septum is a protruding ridge on the cell’s surface and functions as a 
site of cell division (Dahl, 2004). The rpfB mutant resembled wild type cells but 
also appeared slightly longer than wild type. However, the rpfA mutant 
displayed a rough-like or even “wrinkled” appearance at its surface as indicated 
by red arrows, furthermore these cells were bent (white arrows) and had slight 
bulges at a single pole. These phenotypes were exacerbated in the multiple 
mutants; moreover rpfA rpfB and rpfA rpfB rpfC mutant cells were fragile 
as was evidenced by the presence of broken cells (green arrows). Preparation of 
these cells could have compromised the cell walls during the dehydration 
process and made them brittle; however, since all strains were prepared under 
identical conditions, the increased breakage in multiple rpf deletion mutants 
suggests changes in cell wall stability. The septa in these strains were not well 
defined like wild type cells but this is probably due to cell surface defects.  
111 
 
 
Wild type rpfA
 
rpfB rpfArpfB
 
112 
 
rpfArpfB rpfC rpfArpfB::pMVRPFAB
 
 
Figure 38: High magnification Scanning Electron Microscopy images showing cell 
morphological defects associated with rpfA gene loss. Log-phase cultures were 
dehydrated by increasing concentrations of ethanol and coated with gold sputtering. 
Yellow arrows indicate septa; white arrows indicate bending of cells; red arrows indicate 
cell surface defects; blue arrows indicate bulging at a single pole and green arrows 
indicate broken cells. 
 
Heterologous expression of M. tuberculosis rpfA and rpfB genes in the M. 
smegmatis double mutant (rpfA rpfB) restores wild type phenotype, as seen in 
the complemented derivative rpfA rpfB::pMVRPFAB, although the cells seem 
slightly longer than wild type. This observation indicates similar biological 
functions of the Rpf-like proteins but slight differences in specificities between the 
two organisms.   
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4. Discussion 
 
A significant proportion of individuals infected with Mycobacterium tuberculosis, 
harbor LTBI. In these cases the tubercle bacilli survive in the human host, without 
presentation of clinical symptoms, for as long as three decades or more with a 
defined risk of subsequent endogenous reactivation (Lillebaek, et al., 2002). 
Recently, it has been suggested that the bacilli in LTBI undergo limited 
replication as evidenced by the absence of genomic content changes following 
analysis of DNA sequences from M. tuberculosis during three decades of LTBI 
(Yang, et al., 2011). The above findings may also indicate that very little 
interaction between the host immune system and the bacilli in LTBI occurs, thus 
this corroborates the hypothesis that the pathogen is in a genuinely dormant, 
immune subversive state, during LTBI (Yang, et al., 2011). 
 
Rpf, first identified in Mi. luteus (Mukamolova, et al., 1998), the progenitor of the 
Rpf-like protein family, was observed to stimulate growth of dormant, non-
dividing cells of the organism (Mukamolova, et al., 1998). Several Gram-positive 
bacteria, including M. tuberculosis and M. smegmatis, encode rpf-like genes 
within their genomes (Mukamolova, et al., 1998). A 70 residue, lysozyme-like 
domain is conserved in all Rpf-like proteins (Kell & Young, 2000, Mukamolova, et 
al., 2006) and it is this domain that is necessary for the muralytic activity 
displayed by these proteins (Mukamolova, et al., 2006). Mi. luteus Rpf has been 
shown to hydrolyze cell wall material in vitro (Mukamolova, et al., 2006, Telkov, 
et al., 2006) and this compared with the observation that the M. tuberculosis 
RpfB domain structure is comparable to glycoside hydrolases (Cohen-Gonsaud, 
et al., 2005), known to hydrolyze the peptidoglycan (Heidrich, et al., 2002), 
confirms that the Rpf-like proteins, including Mi. luteus Rpf, are peptidoglycan 
hydrolases (Telkov, et al., 2006). It is this mechanism of action, peptidoglycan 
cleavage, that promotes growth and more importantly permits for the bacteria to 
exit the dormant state (Keep, et al., 2006). However, the precise nature of the 
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processes following peptidoglycan cleavage, that leads to reactivation of dormant 
organisms, remain to be unraveled.  
 
Here, we report the characterization of the rpf-like genes in M. smegmatis by 
assessing the effects of gene deletion on survival, growth and cell wall 
homeostasis. M. smegmatis encodes four rpf-like genes as opposed to the five in 
M. tuberculosis (Figure 7), where the former lacks rpfD. The precise biological 
functions of individual Rpf-like proteins have yet to be elucidated; however it is 
currently known that a functional hierarchy exists within the M. tuberculosis Rpf 
protein family, with RpfB and RpfE ranking higher than RpfD (Kana, et al., 2008). 
Furthermore, expression analysis of the rpf genes in M. tuberculosis suggests 
the individual Rpf-like proteins have distinct biological roles during different 
stages of growth and under different conditions of stress (Gupta, et al., 2010). It 
has been suggested that the presence of DUF (Domains of Unknown Function) 
families within protein sequences is indicative of biological functions that are 
specific to certain (environmental) conditions (Bateman, et al., 2010). This may 
provide evidence that RpfB possibly has a distinct biological role under different 
conditions, since it is the sole Rpf which includes such domains in its protein 
sequence Figure 8. Knowledge of the exact specificity of M. tuberculosis rpfD 
gene product is key in providing an explanation to the absence of an orthologue 
in M. smegmatis. The difference in rpf gene complement between M. 
tuberculosis and M. smegmatis could be attributed to the fact that these 
organisms have different lifestyles and different requirements to support growth 
in their respective environmental niches (Howard & Byrd, 2000, Abramovitch, et 
al., 2011, Russell, 2011). Moreover the pathogenic nature of M. tuberculosis may 
demand a greater rpf gene repertoire as evidenced by the observation that all 
pathogenic mycobacterial genomes encode multiple rpf-like genes (Kana & 
Mizrahi, 2009). These data strongly suggest that the rpf-like orthologues may 
have differing biological roles in their respective organisms. 
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The organization of rpfA and rpfB genes is comparable in both M. tuberculosis 
and M. smegmatis, however a dissimilar situation is observed for the 
arrangement of the rpfC and rpfE genes. From the above observations; it is likely 
that RpfA and RpfB proteins in both organisms have similar biological functions, 
further supported by the significant protein sequence identity (65% and 78% in 
RpfA and RpfB respectively) which is observed for the orthologues (Figure 8). 
Moreover, returning functional copies of M. tuberculosis rpfA and rpfB genes 
simultaneously in the M. smegmatis rpfA rpfB double mutant background 
restores wild type phenotypes as observed in this study.  
 
It is possible that rpfC and rpfE orthogues in the abovementioned organisms 
have dissimilar functions. The rpfC and rpfE genes are positioned in the same M. 
smegmatis chromosomal location separated by a single gene (MSMEG_4642) 
whereas in M. tuberculosis they are placed in different regions of the 
chromosome. The function of the intermediate gene (MSMEG_4642) is unclear 
since the gene product is annotated as a hypothetical protein, thus it is unknown 
how the gene affects expression of rpfC or rpfE or both, if at all. Numerous genes 
upstream and downstream rpfC and rpfE are not annotated in both organisms 
making it difficult to ascribe function by gene synteny comparisons. 
 
Loss of up to three of four M. smegmatis rpf-like genes does not result in loss of 
viability, an observation seen in other Gram-positives including M. tuberculosis 
(Hartmann, et al., 2004, Tufariello, et al., 2004, Downing, et al., 2005, Kana, et 
al., 2008). These data indicate that the rpf-like genes are not essential for growth 
in these organisms, contrary to what has been observed in Mi. luteus 
(Mukamolova, et al., 2002). However, the multiple rpfA rpfB and rpfA rpfB 
rpfC mutants seem to display slightly reduced growth rates than the single 
rpfA and rpfB mutants or wild type during lag phase (Figure 33A) when cell 
density is measured by light absorption at 600 nm. Surprisingly, growth of all rpf 
mutants is indistinguishable from wild type when assessed by CFU enumeration 
(Figure 33B) with bacterial clumps forming in late stationary phase for rpfA, 
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rpfA rpfB and rpfA rpfB rpfC mutants (Figure 34). Clumping of the rpfA 
mutant strain culture has also been observed in M. tuberculosis (Downing, et al., 
2004). A possible explanation for the above observation is that the apparent 
reduced growth rates for multiple rpf-like mutants could be as a result of 
inaccurate cell density readings due to dispersed micro-clumps in culture and 
would be consistent with the propensity of mutant strains, defective for two or 
more rpf genes, to clump. Bacterial clumping is documented in numerous other 
bacteria where genes associated with cell wall metabolism have been disrupted 
(Parish, et al., 1997, Stapleton, et al., 2007, Hett, et al., 2008, Nguyen, et al., 
2010); and in some cases the observed clumping in culture is associated with 
bacterial filamentation (Gomez & Bishai, 2000, Hett, et al., 2008, Nguyen, et al., 
2010). However, this is not the case in the multiple rpf-like mutants; filamentation 
is not observed in these strains as assessed by scanning electron microscopy 
(SEM) (Figure 38). In contrast, mutant strains of M. smegmatis defective for rpfA, 
rpfB and rpfC in double or triple gene deletion combinations displayed 
abnormally reduced cell size, severe clumping, and bulging at the poles.  
 
Bacterial filamentation is a growth phenotype that is evident as elongated cells 
forming a chain-like appearance; in most cases due to defects in septum 
formation or septum inhibition and defects in cell division (Samaluru, et al., 2007, 
Hett, et al., 2008, Goley, et al., 2010, England, et al., 2011, Perez-Nunez, et al., 
2011, Shippy, et al., 2011). In other instances, elongation is due to responses to 
various internal or external stresses for some bacteria. The lack of filamentation 
in rpf mutants may indicate that the Rpf-like proteins are not septum specific 
hydrolases and/or solely responsible for cell fragmentation or division since cells 
depleted of these genes have the ability to divide without forming chains. 
However, it has been shown that M. tuberculosis and M. smegmatis RpfB and 
RpfE proteins co-localize to the septa with an endopeptidase, RipA (Hett, et al., 
2007); it has also been demonstrated that RpfB is not compulsory for RipA 
functioning and possibly the interaction is conditional, probably under specific 
stresses (Hett, et al., 2008). These data suggest that RpfB may not be an 
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essential septum hydrolase. However, the SEM images show that the septa are 
not well-defined and seem to be positioned towards a single pole of the cell in 
rpfA rpfB and rpfA rpfB rpfC mutants (Figure 38). Whist the possibility that 
there are actual defects in septum formation or positioning cannot be ruled out, 
these observations may be due to general/mechanical cell distortions, forcing the 
septa to be displaced to another position, closer to a pole, of the cell. 
 
Analysis of cell morphology by SEM also reveals distorted cells for rpfA, rpfA 
rpfB and rpfA rpfB rpfC mutants. The rpfA cells have a wrinkle-like 
appearance, are irregularly shaped and display a slightly bulbous pole which is 
bent at the tip (Figure 38). Mycobacteria grow in a remarkably unipolar manner 
(Aldridge, et al., 2012), and this property could explain the bulbous pole defect 
being seen at a single pole and not both. The abovementioned phenotype is 
exacerbated in the multiple mutants; whereas straight rods, with well-positioned 
septa are observed in wild type and rpfB mutant cells. The wild type phenotype 
is restored in the complemented double mutant (rpfA rpfB::pMVRPFAB), 
although the cells seem slightly longer in this strain. A bulbous pole phenotype 
has been observed in mycobacteria as a result of disruptions to an essential cell 
wall gene, wag31, with its gene product localizing to the poles (Nguyen, et al., 
2007, Kang, et al., 2008). The wag31 gene encodes a cell division protein, 
Antigen 84, which is responsible for cell shape and cell wall synthesis (Nguyen, 
et al., 2007, Kang, et al., 2008). The observed phenotype could be as a result of 
changes in localization of the peptidoglycan biosynthetic or degradative proteins 
(Kang, et al., 2008), which results in disrupted coordination of the two processes 
leading to asymmetrically shaped cells. 
 
It is interesting that the cell morphology phenotype, to some degree, is 
associated with rpfA deletion, individually and in combination, thus it is possible 
that rpfA localizes to the pole(s) and regulates polar growth. A Staphylococcus 
aureus 8325/4 autolysin atl gene product plays a role in cell lysis and separation; 
insertional inactivation of the gene displays a rough outer surface due to absence 
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in peptidoglycan release at its surface (Foster, 1995) possibly this is the case 
with rpfA, rpfA rpfB and rpfA rpfB rpfC mutant cells. These rpf-like 
multiple mutants seemed “fragile” as evidenced by breakages in the cells during 
careful preparation for SEM, which is probably the result of weakening of the cell 
wall due to changes in the peptidoglycan stability. 
 
Although the above cell morphology phenotypes are general observations, there 
are some mutant cells in certain microscopic images that do not display such 
defects (data not shown), indicating heterogeneity within the population. Growth 
and cell division in mycobacteria is asymmetric, giving rise to daughter cells with 
differing elongation rates and sizes thus creating heterogeneity within a clonal 
population consisting of physiologically distinct subpopulations (Aldridge, et al., 
2012). It is speculative that the introduction of mutated copies of rpf genes, 
and/or combinations thereof, into possibly physiologically distinct cells could have 
further exacerbated these effects and resulted in a phenotypically heterogeneous 
population.  A heterogeneous population has been observed in S. aureus mutant 
strains defective in PBP1, a cell wall transpeptidase, and was attributed to be a 
result of disrupted cell division caused by PBP1 inactivation in cells at dissimilar 
stages of the cell cycle (Pereira, et al., 2007). A similar situation may prevail in 
our rpf mutant strains.  
 
The microscopic analysis of cell morphology suggests that the observed 
clumping of rpfA, rpfA rpfB and rpfA rpfB rpfC mutant cultures, Figure 34, 
is not as a result of filamentation. It is clear; however, that the clumping 
phenotype is linked to deletion of rpfA and becomes progressively worse with the 
deletion of further genes in the rpfA mutant background. A similar situation has 
been observed in S. aureus; where deletion of genes encoding lytic 
transglycosylases, isaA and sceD, where the sceD mutant alone displays 
clumping and the phenotype is exacerbated by deletion of both genes (Stapleton, 
et al., 2007). IsaA and SceD are autolysins like the Rpf-like proteins and share 
similar hydrolytic bond specificities in peptidoglycan, the -1,4 glycosidic bond 
119 
 
cleavage between NAM and NAG residues. It is therefore possible that the cause 
for clumping seen in the isaA and sceD mutants, which is not associated with 
filamentation, is the same to that of rpf-like gene deletion. Defects in cell 
separation and surface properties are proposed as explanations to the observed 
clumping in broth (Foster, 1995, Kajimura, et al., 2005, Stapleton, et al., 2007); 
the latter sounds more probable. Hence it is also possible that deletion of multiple 
rpf genes results in changes in peptidoglycan composition leading to overall 
differences in cell hydrophobicity or charge. In this context, there may also be 
differences in mycolic acid profiles. These possibilities are currently being 
investigated. 
 
Although there are no observable differences in growth between wild type and 
rpf-like mutants in liquid culture under those conditions tested (Figure 33); growth 
defects are observed, as assessed by biofilm formation (Figure 37). Biofilm 
formation is retarded for the multiple rpf-like mutants, whereas the single deletion 
mutants exhibit the formation of mature biofilms. Bacterial biofilms are surface-
associated cell aggregates, forming communities which are then encompassed 
by an extracellular matrix, the composition of which can differ between organisms 
(Donlan, 2002). Biofilm formation involves a few stages of development, which 
include surface attachment, microcolony formation and maturation (Stanley & 
Lazazzera, 2004). Commencement of the abovementioned stages is influenced 
and directed by environmental signals and bacterial regulatory pathways (Stanley 
& Lazazzera, 2004), ensuring that the bacteria initiate and form successful 
biofilm structures in appropriate environments (Stanley & Lazazzera, 2004). The 
occurrence of bacterial biofilms varies, from natural aquatic systems to implanted 
medical devices, and each type is well adapted to its environment (Donlan, 
2002). Microorganisms within biofilms are dissimilar to their planktonic forms at 
the genetic level, with respect to gene transcription. Bacterial cells in a biofilm 
have several advantages over their planktonic counterparts; since the biofilm 
ecology provides a suitable environment for cell-cell signaling which maintains 
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structure, exchange of genetic material, formation of nutrient gradients and the 
community is well protected against antibiotic treatment (Donlan, 2002). 
 
Biofilms are relevant in the clinical setting and human disease; several 
pathogens responsible for chronic infections have been associated with biofilm 
formation (Hall-Stoodley & Stoodley, 2009). Bacteria in biofilms are highly 
recalcitrant to antibiotic treatment and such infections persist irrespective of host 
immune responses (Hall-Stoodley & Stoodley, 2009). The observed “resistance” 
to antibiotics in M. tuberculosis is due to the presence of a heterogeneous 
population within the biofilm consisting of slow-growing cells, cells in stationary 
phase and persisters (Lewis, 2007, Ojha, et al., 2008). Persisters survive 
antibiotic treatment irrespective of drug concentration used, an in vitro 
observation seen in M. tuberculosis (Ojha, et al., 2008); moreover the extra-
cellular matrix guards against immune cells (Lewis, 2007). 
 
The rpfA rpfB and rpfA rpfB rpfC mutants display under-developed 
biofilms with a few loose colony islands floating on the liquid surface with most of 
the bacterial cells settling at the bottom of the wells. It may seem that the multiple 
mutants had an inability to form biofilms but it may be more likely that these 
mutants were growing at a much reduced rate thus the initial stages of biofilm 
formation may have been disrupted. A defect in biofilm formation has been linked 
to colony morphology alterations (Bourai, et al., 2011) due to disrupted cell wall 
genes such as lpqB and M. tuberculosis Rv2911; the former gene product being 
responsible for processes in cell wall homeostasis and the latter encoding 
DacB2, which plays a role in peptidoglycan synthesis (Nguyen, et al., 2010). The 
above observation is consistent with what is seen in this study (Figure 36). A 
reduction in serpentine cording is observed for rpfA rpfB and rpfA rpfB 
rpfC mutant colonies, thus colonies appear smoother with regular edges. A 
similar phenotype is seen in M. tuberculosis rpfA rpfB mutant (Russell-
Goldman, et al., 2008). It is suggested that a smoother colony phenotype is likely 
due to alterations in cell surface properties caused by a reduction in
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hydrophobicity (Dahl & Lau Bonilla, 2011). It is probable that such changes in cell 
surface properties might impact on cell-cell interactions within a community, in 
the case of biofilms, thus explaining the observed defect in biofilm formation with 
the multiple mutants (Bourai, et al., 2011). 
 
It was most surprising that the rpf-like mutants, more especially the multiple 
mutants, lacked an SDS susceptibility phenotype since it is observed that several 
mycobacterial mutants that display a defect in cell wall construction are sensitive 
to this detergent (Kocincova, et al., 2004). Moreover, it has been shown that M. 
tuberculosis quadruple rpf-like mutants that are deficient in rpfB and rpfE display 
hypersensitivity to the detergent (Kana, et al., 2008). This may be indicative of 
the differences in Rpf-like protein specificities between the two organisms or 
other mechanisms of resistance to detergent in M. smegmatis. However; the 
multiple rpf-like mutants and not the single mutants display a 2-4 log increase in 
susceptibility to erythromycin and vancomycin when compared to the wild type 
(Figure 35E & F), a phenotype also observed in M. tuberculosis (Kana, et al., 
2010). In E. coli; it has also been shown that multiple hydrolase mutants and not 
single mutants, display a similar antibiotic susceptibility phenotype (Korsak, et al., 
2005). Generally, increased susceptibility to antibiotics is due to compromised 
cell wall integrity (Korsak, et al., 2005, Nguyen, et al., 2010), however it is 
unclear why the mutants display a high degree of susceptibility specifically to 
erythromycin and vancomycin. Heterologous expression of M. tuberculosis rpfA 
and rpfB genes in M. smegmatis rpfA rpfB mutant background restored wild 
type phenotypes in all cases, indicating similarities in biological functions of Rpf-
like proteins between the two organisms. 
 
4.1 Concluding remarks 
 
Taken together, these results are indicative of a loss of bacterial cell wall integrity 
in rpf mutants and our data suggest that rpfA is likely to be largely responsible for 
bacterial cell wall integrity maintenance. Some of the phenotypes mentioned 
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above are associated with the loss of rpfA further indicating that the Rpf-like 
proteins may indeed have distinct biological roles and are not functionally 
redundant as previously suggested (Downing, et al., 2004). 
 
Further experimental work needs to be undertaken in order to prove or disprove 
the above speculations and to explain some of the observed phenotypes. 
Localization of Rpf proteins within cells will provide insight as to where the 
proteins exert their biological roles and this may reveal specificities of each of the 
Rpf-like proteins. 
 
In summary, we have demonstrated that the rpf genes play an important role in 
some essential cell division processes and are likely to regulate bacterial growth 
through multiple mechanisms. The mechanism through which these proteins 
stimulate growth remains a mystery but is likely to be some essential function 
associated with remodeling of the bacterial cell wall. These and other such 
questions are currently being investigated.  
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5. Appendices 
 
5.1 Appendix A: Culture media  
 
Luria-Bertani Agar (LA) 
5g yeast extract, 10g tryptone, 10g NaCl, 1.5g agar, 1000 ml sdH2O 
 
Luria-Bertani Broth (LB) 
5g yeast extract, 10g tryptone, 10g NaCl, 1000 ml sdH20  
 
2TY 
10g yeast extract, 16g tryptone, 5g NaCl, 1000 ml sdH2O 
 
Middlebrook 7H9 
4.7 g Difco Middlebrook 7H9 powder, 2 ml glycerol, 900 ml dH2O, 100 ml 10X 
glucose-salt, 2 ml Tween80 or 2 ml Tyloxapol 
 
Middlebrook 7H10 
19 g Difco Middlebrook 7H10 powder, 5 ml glycerol, 900 ml dH2O, 100 ml 10X 
glucose-salt 
 
Middlebrook 7H11 
21 g Difco Middlebrook 7H11 powder, 5 ml glycerol, 900 ml dH2O, 100 ml 10X 
glucose-salt 
 
Glucose salt             10 g glucose, 4.25 g NaCl, 500 ml dH2O 
 
Media was sterilized by autoclaving at 121°C for 20 min 
 
124 
 
 
 
5.2 Appendix B: Solutions  
 
Plasmid DNA preparation solutions 
1 M Tris-HCl              60.56 g Tris, pH 8.0 with HCl, 500 ml dH2O final volume 
0.5 M EDTA        18.6 g powder, pH 8.0 with NaOH, dH2O 
 
Soln I                   50 nM glucose, 25 mM Tris-HCl, 10 mM EDTA, pH 8.0 
Soln II                  0.2 M NaOH, 1.0% SDS 
Soln III                 5 M potassium acetate, 11.5 ml glacial acetic acid, 88.5 dH20, 
                            pH 4.8  
 
TE                       1 ml 1 M Tris-HCl, 2 ml 0.5 M EDTA 
TAE buffer           242 g Tris base, 100 ml 0.5 M EDTA, 57.1 ml glacial acetic      
                             acid, pH 8.0, 1000 ml final volume dH2O 
 
Southern Blotting solutions  
20X SSC            175.3 g NaCl, 88.2g sodium citrate, make up to 1000 ml, pH 7.0 
Soln I                 10 ml 20X SSC, 1 ml 10% SDS, 89 ml dH2O 
Soln II                2.5 ml 20X SSC, 1 ml 10% SDS, 96.5 ml 
10% SDS           10 g powder, 100 ml sdH20 
 
Maleic acid buffer   116.1 g maleic acid powder, 87. 66 g NaCl, pH 7.5 with  
                                NaOH pellets, make 1000 ml final volume with dH2O    
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5.3 Appendix C: Plasmids and molecular weight markers 
 
Plasmids 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A1: Knockout construct, pSVRPFA, carrying rpfC and rpfE deletion 
alleles for construction of rpfC and rpfE mutants. 
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Figure A2: Integrating vector carrying M. tuberculosis rpfA and rpfB genes under 
the control of their native promoter regions, for complementation purposes. 
 
Lambda DNA molecular weight markers  
       
 DNA molecular weight marker III, IV and VI supplied by Roche Applied Science  
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